Document:

EX-10.1

 Exhibit 10.1 
 Ruth’s Hospitality Group, Inc. 
 Amended and Restated 

2005 Long-Term Equity Incentive Plan 
 1. Purpose. 
 This plan shall be known as the Amended and Restated
Ruth’s Hospitality Group, Inc. 2005 Long-Term Equity Incentive Plan (the “Plan”). The purpose of the Plan shall be to promote the long-term growth and profitability of Ruth’s Hospitality Group, Inc. (the “Company”) and
its Subsidiaries by (i) providing certain directors, officers and employees of, and certain other individuals who perform services for, the Company and its Subsidiaries with incentives to maximize stockholder value and otherwise contribute to
the success of the Company and (ii) enabling the Company to attract, retain and reward the best available persons for positions of responsibility. Grants of incentive or non-qualified stock options, restricted stock, restricted stock units,
deferred stock units, performance awards, or any combination of the foregoing may be made under the Plan. 
 2. Definitions.

 (a) “Board of Directors” and “Board” mean the board of directors of the Company. 

(b) “Cause” means (i) a Participant’s theft or embezzlement, or attempted theft or embezzlement, of money or property
of the Company, a Participant’s perpetration or attempted perpetration of fraud, or a Participant’s participation in a fraud or attempted fraud, on the Company or a Participant’s unauthorized appropriation of, or a Participant’s
attempt to misappropriate, any tangible or intangible assets or property of the Company, (ii) any act or acts of disloyalty or misconduct by a participant injurious to the interest, property, operations, business or reputation of the Company or
a Participant’s commission of a felony or crime or act of moral turpitude or (iii) a Participant’s willful disregard of a directive given by a superior or the Board or a violation of a Company employment policy. 

(c) “Change in Control” means the occurrence of one of the following events: 

(i) if any “person” or “group” as those terms are used in Sections 13(d) and 14(d) of the Exchange Act
or any successors thereto, other than an Exempt Person, is or becomes the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act or any successor thereto), directly or indirectly, of securities of the Company representing 50%
or more of the combined voting power of the Company’s then outstanding securities; or 
 (ii) during any
period of two consecutive years, individuals who at the beginning of such period constitute the Board and any new directors whose election by the Board or nomination for election by the Company’s stockholders was approved by at least two-thirds
of the directors then still in office who either were directors at the beginning of the period or whose election was previously so approved, cease for any reason to constitute a majority thereof; or 

 (iii) consummation of a merger or consolidation of the Company with any
other corporation, other than a merger or consolidation (A) which would result in all or a portion of the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by
being converted into voting securities of the surviving entity) more than 50% of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation or (B) by
which the corporate existence of the Company is not affected and following which the Company’s chief executive officer and directors retain their positions with the Company (and constitute at least a majority of the Board); or 

(iv) consummation of a plan of complete liquidation of the Company or a sale or disposition by the Company of all or
substantially all the Company’s assets, other than a sale to an Exempt Person. 
 (d) “Code” means the Internal
Revenue Code of 1986, as amended. 
 (e) “Committee” means the Compensation Committee of the Board, which shall consist
solely of two or more members of the Board, each of whom shall be independent, as defined by the Nasdaq Marketplace rules or the rules of any other national securities exchange on which any securities of the Company are listed for trading, and
if not listed for trading, by the Nasdaq Marketplace rules. 
 (f) “Common Stock” means the Common Stock, par value
$0.01 per share, of the Company, and any other shares into which such stock may be changed by reason of a recapitalization, reorganization, merger, consolidation or any other change in the corporate structure or capital stock of the Company.

 (g) “Competition” is deemed to occur if a person whose employment with the Company or its Subsidiaries has
terminated obtains a position as a full-time or part-time employee of, as a member of the board of directors of, or as a consultant or advisor with or to, or acquires an ownership interest in excess of 5% of, a corporation, partnership, firm or
other entity that engages in any of the businesses of the Company or any Subsidiary with which the person was involved in a management role at any time during his or her last five years of employment with or other service for the Company or any
Subsidiaries. 
 (h) “Disability” occurs if a participant: 

(i) is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental
impairment which can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, or 
 (ii) is, by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than 12 months,
receiving income replacement benefits for a period of not less than 3 months under an accident and health plan covering employees of the participant’s employer. 

  
 2 

 (i) “Exchange Act” means the Securities Exchange Act of 1934, as amended.

 (j) “Excluded Shares” means Shares which are so designated in Sections 7, 8, 9 and 17 hereof. 

(k) “Exempt Person” means (i) Madison Dearborn Partners, LLC, Madison Dearborn Partners III, L.P., Madison Dearborn Capital
Partners III, L.P., Madison Dearborn Special Equity III, L.P. or Special Advisors Fund I, LLC or any of their affiliates, (ii) any person, entity or group under the control of any party included in clause (i), or (iii) any employee benefit
plan of the Company or a trustee or other administrator or fiduciary holding securities under an employee benefit plan of the Company. 
 (l) “Family Member” has the meaning given to such term in General Instructions A.1(a)(5) to Form S-8 under the Securities Act of 1933, as amended, and any successor thereto. 

(m) “Fair Market Value” of a share of Common Stock of the Company means, as of the date in question, the officially-quoted
closing selling price of the stock (or if no selling price is quoted, the bid price) on the principal securities exchange on which the Common Stock is then listed for trading (the “Market”) for the applicable trading day or, if the Common
Stock is not then listed in the Market, the Fair Market Value shall be the fair value of the Common Stock determined in good faith by the Board; provided, however, that when shares received upon exercise of an option are immediately sold in the open
market, the net sale price received may be used to determine the Fair Market Value of any shares used to pay the exercise price or applicable withholding taxes and to compute the withholding taxes. 

(n) “Incentive Stock Option” means an option conforming to the requirements of Section 422 of the Code and any successor
thereto. 
 (o) “Non-Employee Director” has the meaning given to such term in Rule 16b-3 under the Exchange Act and any
successor thereto. 
 (p) “Non-qualified Stock Option” means any stock option other than an Incentive Stock Option.

 (q) “Other Company Securities” mean securities of the Company other than Common Stock, which may include, without
limitation, unbundled stock units or components thereof, debentures, preferred stock, warrants and securities convertible into or exchangeable for Common Stock or other property. 

(r) “Retirement” means retirement as defined under any Company pension plan or retirement program or termination of one’s
employment on retirement with the approval of the Committee. 
 (s) “Subsidiary” means a corporation or other entity of
which outstanding shares or ownership interests representing 50% or more of the combined voting power of such corporation or other entity entitled to elect the management thereof, or such lesser percentage as may be approved by the Committee, are
owned directly or indirectly by the Company. 

  
 3 

 3. Administration. 
 The Plan shall be administered by the Committee. Subject to the provisions of the Plan, the Committee shall be authorized to (i) select persons to participate in the Plan, (ii) determine the
form and substance of grants made under the Plan to each participant, and the conditions and restrictions, if any, subject to which such grants will be made, (iii) certify that the conditions and restrictions applicable to any grant have been
met, (iv) modify the terms of grants made under the Plan, (v) interpret the Plan and grants made thereunder, (vi) make any adjustments necessary or desirable in connection with grants made under the Plan to eligible participants
located outside the United States and (vii) adopt, amend, or rescind such rules and regulations, and make such other determinations, for carrying out the Plan as it may deem appropriate. Decisions of the Committee on all matters relating to the
Plan shall be in the Committee’s sole discretion and shall be conclusive and binding on all parties. The validity, construction, and effect of the Plan and any rules and regulations relating to the Plan shall be determined in accordance with
applicable federal and state laws and rules and regulations promulgated pursuant thereto and the rules and regulations of the principal securities exchange on which the Common Stock is then listed for trading. No member of the Committee and no
officer of the Company shall be liable for any action taken or omitted to be taken by such member, by any other member of the Committee or by any officer of the Company in connection with the performance of duties under the Plan, except for such
person’s own willful misconduct or as expressly provided by statute. 
 The expenses of the Plan shall be borne by the
Company. The Plan shall not be required to establish any special or separate fund or make any other segregation of assets to assume the payment of any award under the Plan, and rights to the payment of such awards shall be no greater than the rights
of the Company’s general creditors. 
 4. Shares Available for the Plan. 

Subject to adjustments as provided in Section 16 hereof, an aggregate of 3,862,500 shares of Common Stock may be issued pursuant to
the Plan (collectively, the “Shares”). Such Shares may be in whole or in part authorized and unissued or held by the Company as treasury shares. If any grant under the Plan expires or terminates unexercised, becomes unexercisable or is
forfeited as to any Shares, or is tendered or withheld as to any shares in payment of the exercise price of the grant or the taxes payable with respect to the exercise, then such unpurchased, forfeited, tendered or withheld Shares shall thereafter
be available for further grants under the Plan. No more than 10% of the total Shares authorized for issuance under the Plan may constitute Excluded Shares. 
 Without limiting the generality of the foregoing provisions of this Section 4 or the generality of the provisions of Sections 3, 6 or 17 or any other section of this Plan, the Committee may, at any
time or from time to time, and on such terms and conditions (that are consistent with and not in contravention of the other provisions of this Plan) as the Committee may, in its sole discretion, determine, enter into agreements (or take other
actions with respect to the options) for new options containing terms (including exercise prices) more (or less) favorable than the outstanding options. 

  
 4 

 5. Participation. 
 Participation in the Plan shall be limited to those directors (including Non-Employee Directors), officers (including non-employee officers) and employees of, and other individuals performing services
for, the Company and its Subsidiaries selected by the Committee (including participants located outside the United States). Nothing in the Plan or in any grant thereunder shall confer any right on a participant to continue in the service or employ
as a director or officer of or in the performance of services for the Company or a Subsidiary or shall interfere in any way with the right of the Company or a Subsidiary to terminate the employment or performance of services or to reduce the
compensation or responsibilities of a participant at any time. By accepting any award under the Plan, each participant and each person claiming under or through him or her shall be conclusively deemed to have indicated his or her acceptance and
ratification of, and consent to, any action taken under the Plan by the Company, the Board or the Committee. 
 Incentive Stock
Options or Non-qualified Stock Options, restricted stock awards, restricted stock unit or deferred stock unit awards, performance awards, or any combination thereof, may be granted to such persons and for such number of Shares as the Committee shall
determine (such individuals to whom grants are made being sometimes herein called “optionees” or “grantees,” as the case may be). Determinations made by the Committee under the Plan need not be uniform and may be made selectively
among eligible individuals under the Plan, whether or not such individuals are similarly situated. A grant of any type made hereunder in any one year to an eligible participant shall neither guarantee nor preclude a further grant of that or any
other type to such participant in that year or subsequent years. 
 6. Incentive and Non-qualified Options. 

The Committee may from time to time grant to eligible participants Incentive Stock Options, Non-qualified Stock Options, or any
combination thereof; provided that the Committee may grant Incentive Stock Options only to eligible employees of the Company or its subsidiaries (as defined for this purpose in Section 424(f) of the Code or any successor thereto). In any one
calendar year, the Committee shall not grant to any one participant options to purchase a number of shares of Common Stock in excess of 1,181,250 (as adjusted pursuant to Section 15 hereof). The options granted shall take such form as the
Committee shall determine, subject to the following terms and conditions. 
 It is the Company’s intent that Non-qualified
Stock Options granted under the Plan not be classified as Incentive Stock Options, that Incentive Stock Options be consistent with and contain or be deemed to contain all provisions required under Section 422 of the Code and any successor
thereto, and that any ambiguities in construction be interpreted in order to effectuate such intent. If an Incentive Stock Option granted under the Plan does not qualify as such for any reason, then to the extent of such non-qualification, the stock
option represented thereby shall be regarded as a Non-qualified Stock Option duly granted under the Plan, provided that such stock option otherwise meets the Plan’s requirements for Non-qualified Stock Options. 

(a) Price. The price per Share deliverable upon the exercise of each option (“exercise price”) may not be less than 100%
of the Fair Market Value of a share of Common Stock as of the date of grant of the option, and in the case of the grant of any Incentive Stock Option to an employee who, at the time of the grant, owns more than 10% of the total combined voting power
of all classes of stock of the Company or any of its Subsidiaries, the exercise price may not be less than 110% of the Fair Market Value of a share of Common Stock as of the date of grant of the option, in each case unless otherwise permitted by
Section 409A and Section 422 of the Code or any successor thereto. 

  
 5 

 (b) Payment. Options may be exercised, in whole or in part, upon payment of the
exercise price of the Shares to be acquired. Unless otherwise determined by the Committee, payment shall be made (i) in cash (including check, bank draft, money order or wire transfer of immediately available funds), (ii) by delivery of
outstanding shares of Common Stock with a Fair Market Value on the date of exercise equal to the aggregate exercise price payable with respect to the options’ exercise, (iii) by simultaneous sale through a broker reasonably acceptable to
the Committee of Shares acquired on exercise, as permitted under Regulation T of the Federal Reserve Board or (iv) by any combination of the foregoing. 
 In the event a grantee elects to pay the exercise price payable with respect to an option pursuant to clause (ii) above, (A) only a whole number of share(s) of Common Stock (and not fractional
shares of Common Stock) may be tendered in payment and (B) Common Stock must be delivered to the Company. Delivery for this purpose may, at the election of the grantee, be made either by (1) physical delivery of the certificate(s) for all
such shares of Common Stock tendered in payment of the price, accompanied by duly executed instruments of transfer in a form acceptable to the Company, or (2) direction to the grantee’s broker to transfer, by book entry, such shares of
Common Stock from a brokerage account of the grantee to a brokerage account specified by the Company. When payment of the exercise price is made by delivery of Common Stock, the difference, if any, between the aggregate exercise price payable with
respect to the option being exercised and the Fair Market Value of the shares of Common Stock tendered in payment (plus any applicable taxes) shall be paid in cash. No grantee may tender shares of Common Stock having a Fair Market Value exceeding
the aggregate exercise price payable with respect to the option being exercised (plus any applicable taxes). 
 (c) Terms of
Options. The term during which each option may be exercised shall be determined by the Committee, but if required by the Code and except as otherwise provided herein, no option shall be exercisable in whole or in part more than ten years from
the date it is granted, and no Incentive Stock Option granted to an employee who at the time of the grant owns more than 10% of the total combined voting power of all classes of stock of the Company or any of its Subsidiaries shall be exercisable
more than five years from the date it is granted. All rights to purchase Shares pursuant to an option shall, unless sooner terminated, expire at the date designated by the Committee. The Committee shall determine the date on which each option shall
become exercisable and may provide that an option shall become exercisable in installments. The Shares constituting each installment may be purchased in whole or in part at any time after such installment becomes exercisable, subject to such minimum
exercise requirements as may be designated by the Committee. Prior to the exercise of an option and delivery of the Shares represented thereby, the optionee shall have no rights as a stockholder with respect to any Shares covered by such outstanding
option (including any dividend or voting rights). 
 (d) Limitations on Grants. If required by the Code, the aggregate
Fair Market Value (determined as of the grant date) of Shares for which an Incentive Stock Option is exercisable for the first time during any calendar year under all equity incentive plans of the Company and its Subsidiaries (as defined in
Section 422 of the Code or any successor thereto) may not exceed $100,000. 

  
 6 

 (e) Termination; Forfeiture. 

(i) Death or Disability. If a participant ceases to be a director, officer or employee of, or to perform other
services for, the Company or any Subsidiary due to death or Disability, a number of options equal to the sum of (i) the number of options that were exercisable on the date of the participant’s death or Disability plus (ii) such
additional number of options to which the participant would have been entitled had the participant’s employment continued for one year following the date of termination, shall become fully vested and exercisable and shall remain so for a period
of 180 days from the date of such death or Disability; provided that the participant does not engage in Competition during such 180-day period unless he or she received written consent to do so from the Board or the Committee; provided further that
the Board or Committee may extend such exercise period (and related non-competition period) in its discretion, but in no event may such extended exercise period extend beyond the expiration date of the options. Remaining options that were not
exercisable on the date of a Participant’s death or Disability as set forth in the preceding sentence shall expire and be forfeited. Notwithstanding the foregoing, if the Disability giving rise to the termination of employment is not within the
meaning of Section 22(e)(3) of the Code or any successor thereto, Incentive Stock Options not exercised by such participant within 90 days after the date of termination of employment will cease to qualify as Incentive Stock Options and will be
treated as Non-qualified Stock Options under the Plan if required to be so treated under the Code. 
 (ii)
Retirement. If a participant ceases to be a director, officer or employee of, or to perform other services for, the Company or any Subsidiary upon the occurrence of his or her Retirement, (A) all of the participant’s options that
were exercisable on the date of Retirement shall remain exercisable for, and shall otherwise terminate at the end of, a period of 90 days after the date of Retirement, but in no event after the expiration date of the options; provided that the
participant does not engage in Competition during such 90 day period unless he or she receives written consent to do so from the Board or the Committee; provided further that the Board or the Committee may extend such exercise period (and related
non-competition period) in its discretion, but in no event may such extended exercise period extend beyond the expiration date of the options, and (B) all of the participant’s options that were not exercisable on the date of Retirement
shall be forfeited immediately upon such Retirement; provided, however, that such options may become fully vested and exercisable in the discretion of the Committee. Notwithstanding the foregoing, Incentive Stock Options not exercised by such
participant within 90 days after Retirement will cease to qualify as Incentive Stock Options and will be treated as Non-qualified Stock Options under the Plan if required to be so treated under the Code. 

(iii) Termination for Cause. If a participant ceases to be a director, officer or employee of, or to perform other
services for, the Company or a Subsidiary due to Cause, all of the participant’s options shall expire and be forfeited on the date the Company or a Subsidiary delivers to the Participant notice of termination of employment for Cause, whether or
not then exercisable. 

  
 7 

 (iv) Other Termination. Unless otherwise determined by the Committee,
if a participant ceases to be a director, officer or employee of, or to otherwise perform services for, the Company or a Subsidiary for any reason other than death, Disability, Retirement or discharge for Cause, (A) all of the
participant’s options that were exercisable on the date of such cessation shall remain exercisable for, and shall otherwise terminate at the end of, a period of 30 days after the date of such cessation, but in no event after the expiration date
of the options; provided that the participant does not engage in Competition during such 30-day period unless he or she receives written consent to do so from the Board or the Committee; provided further that the Board or Committee may extend such
exercise period (and related non-competition period) in its discretion, but in no event may such extended exercise period extend beyond the expiration date of the options, and (B) all of the participant’s options that were not exercisable
on the date of such cessation shall be forfeited immediately upon such cessation. 
 (v) Change in
Control. If there is a Change in Control of the Company and a Participant is terminated from being a director, officer or employee of, or from performing other services for, the Company or a Subsidiary within one year after such Change in
Control, all of the participant’s options shall become fully vested and exercisable upon such termination and shall remain so for up to one year after the date of termination, but in no event after the expiration date of the options. In
addition, the Committee shall have the authority to grant options that become fully vested and exercisable automatically upon a Change in Control, whether or not the grantee is subsequently terminated. 

(f) Grant of Reload Options. The Committee may provide (either at the time of grant or exercise of an option), in its discretion,
for the grant to a grantee who exercises all or any portion of an option (“Exercised Options”) and who pays all or part of such exercise price with shares of Common Stock, of an additional option (a “Reload Option”) for a number
of shares of Common Stock equal to the sum (the “Reload Number”) of the number of shares of Common Stock tendered for the Exercised Options plus, if so provided by the Committee, the number of shares of Common Stock, if any, tendered by
the grantee in connection with the exercise of the Exercised Options to satisfy any federal, state or local tax withholding requirements. The terms of each Reload Option, including the date of its expiration and the terms and conditions of its
exercisability and transferability, shall be the same as the terms of the Exercised Option to which it relates, except that (i) the grant date for each Reload Option shall be the date of exercise of the Exercised Option to which it relates and
(ii) the exercise price for each Reload Option shall be the Fair Market Value of the Common Stock on the grant date of the Reload Option. 

7. Restricted Stock. 
 The Committee may at any time and from time to time grant Shares of restricted stock under the Plan to such participants and in such amounts as it determines. Each grant of Shares of restricted stock
shall specify the applicable restrictions on such Shares, the duration of such 

  
 8 

 
restrictions (which shall be at least six months except as otherwise determined by the Committee or provided in the third paragraph of this Section 7; provided that any such Shares issued
with restrictions that have a duration of less than three years will constitute Excluded Shares), and the time or times at which such restrictions shall lapse with respect to all or a specified number of Shares that are part of the grant.

 The participant will be required to pay the Company the aggregate par value of any Shares of restricted stock (or such larger
amount as the Board may determine to constitute capital under Section 154 of the Delaware General Corporation Law, as amended, or any successor thereto) within ten days of the date of grant, unless such Shares of restricted stock are treasury
shares. Unless otherwise determined by the Committee, certificates representing Shares of restricted stock granted under the Plan will be held in escrow by the Company on the participant’s behalf during any period of restriction thereon and
will bear an appropriate legend specifying the applicable restrictions thereon, and the participant will be required to execute a blank stock power therefor. Except as otherwise provided by the Committee, during such period of restriction the
participant shall have all of the rights of a holder of Common Stock, including but not limited to the rights to receive dividends and to vote, and any stock or other securities received as a distribution with respect to such participant’s
restricted stock shall be subject to the same restrictions as then in effect for the restricted stock. 
 Except as otherwise
provided by the Committee, if a participant ceases to be a director, officer or employee of, or to otherwise perform services for, the Company and its Subsidiaries due to death or Disability during any period of restriction, a number of shares of
restricted stock equal to the sum of (i) the number of shares of restricted stock for which the restrictions have lapsed plus (ii) the number of shares of restricted stock for which the restrictions will have lapsed within one year
following the date of termination. At such time as a participant ceases to be a director, officer or employee of, or otherwise performing services for, the Company or its Subsidiaries for any other reason, all Shares of restricted stock granted to
such participant on which the restrictions have not lapsed shall be immediately forfeited to the Company. 
 If there is a
Change in Control of the Company and a participant is terminated from being a director, officer or employee of, or from performing other services for, the Company or a subsidiary within one year after such Change in Control, all restrictions on
Shares of restricted stock granted to such participant shall lapse. In addition, the Committee shall have the authority to grant shares of restricted stock with respect to which all restrictions shall lapse automatically upon a Change in Control,
whether or not the grantee is subsequently terminated. 
 8. Restricted Stock Units; Deferred Stock Units. 

The Committee may at any time and from time to time grant restricted stock units under the Plan to such participants and in such amounts
as it determines. Each grant of restricted stock units shall specify the applicable restrictions on such units, the duration of such restrictions (which shall be at least six months except as otherwise determined by the Committee or provided in the
third paragraph of this Section 8; provided that any such restricted stock units issued with restrictions that have a duration of less than three years will constitute Excluded Shares), and the time or times at which such restrictions shall
lapse with respect to all or a specified number of units that are part of the grant. 

  
 9 

 Each restricted stock unit shall be equivalent in value to one share of Common Stock and
shall entitle the participant to receive from the Company at the end of the vesting period (the “Vesting Period”) applicable to such unit one Share, unless the participant elects in a timely fashion to defer the receipt of such Shares, as
provided below. Restricted stock units may be granted without payment of cash or consideration to the Company; provided that participants shall be required to pay to the Company the aggregate par value of the Shares received from the Company within
ten days of the issuance of such Shares unless such Shares are treasury shares. 
 Except as otherwise provided by the
Committee, during the restriction period the participant shall not have any rights as a shareholder of the Company; provided that the participant shall have the right to receive accumulated dividends or distributions with respect to the
corresponding number of shares of Common Stock underlying each restricted stock unit at the end of the Vesting Period, unless such restricted stock units are converted into deferred stock units, in which case such accumulated dividends or
distributions shall be paid by the Company to the participant at such time as the deferred stock units are converted into Shares. 
 Except as otherwise provided by the Committee, if a participant ceases to be a director, officer or employee of, or to otherwise perform services for, the Company or any Subsidiary due to death,
Disability or Retirement during any period of restriction, all restrictions on restricted stock units granted to such participant shall lapse. At such time as a participant ceases to be a director, officer or employee of, or otherwise performing
services for, the Company or any Subsidiary for any other reason, all restricted stock units granted to such participant on which the restrictions have not lapsed shall be immediately forfeited to the Company. 

If there is a Change in Control of the Company and a participant is terminated from being a director, officer or employee of, or from
performing other services for, the Company or any Subsidiary within one year after such Change in Control, all restrictions on restricted stock units granted to such participant shall lapse. In addition, the Committee shall have the authority to
grant restricted stock units with respect to which all restrictions shall lapse automatically upon a Change in Control, whether or not the grantee is subsequently terminated. 
 A participant may elect by written notice to the Company, which notice must be made before the later of (i) the close of the tax year preceding the year in which the restricted stock units are
granted or (ii) 30 days of first becoming eligible to participate in the Plan (or, if earlier, the last day of the tax year in which the participant first becomes eligible to participate in the plan) and on or prior to the date the restricted
stock units are granted, to defer the receipt of all or a portion of the Shares due with respect to the vesting of such restricted stock units; provided that the Committee may impose such additional restrictions with respect to the time at which a
participant may elect to defer receipt of Shares subject to the deferral election, and any other terms with respect to a grant of restricted stock units to the extent the Committee deems necessary to enable the participant to defer recognition of
income with respect to such units until the Shares underlying such units are issued or distributed to the participant. Upon such deferral, the restricted stock units so deferred shall be converted into deferred stock units. Except as provided below,
delivery of Shares with respect to deferred stock units shall be made at the end of the deferral period set forth in the participant’s deferral election notice (the “Deferral Period”). Deferral Periods shall be no less than one year
after the vesting date of the applicable restricted stock units. 

  
 10 

 Except as otherwise provided by the Committee, during such Deferral Period the participant
shall not have any rights as a shareholder of the Company; provided that, the participant shall have the right to receive accumulated dividends or distributions with respect to the corresponding number of shares of Common Stock underlying each
deferred stock unit at the end of the Deferral Period when such deferred stock units are converted into Shares. 
 Except as
otherwise provided by the Committee, if a Participant ceases to be a director, officer or employee of, or to otherwise perform services for, the Company or any Subsidiary upon his or her death prior to the end of the Deferral Period, the participant
shall receive payment in Shares in respect of such participant’s deferred stock units which would have matured or been earned at the end of such Deferral Period as if the applicable Deferral Period had ended as of the date of such
participant’s death. 
 Except as otherwise provided by the Committee, if a participant ceases to be a director, officer or
employee of, or to otherwise perform services for, the Company or any Subsidiary due to a Disability or upon Retirement or for any other reason except termination for Cause prior to the end of the Deferral Period, the participant shall receive
payment in Shares in respect of such participant’s deferred stock units at the end of the applicable Deferral Period or on such accelerated basis as the Committee may determine, to the extent permitted by regulations issued under
Section 409A(a)(3) of the Code. Provided, however, in the case of any “specified employee” as defined in Section 409A of the Code, distributions to such person, as a result of a Retirement or other reason other than for cause,
may not be made earlier than a date which is (A) 6 months following the date of separation from service or (B) such participant’s death. 
 Except as otherwise provided by the Committee, if a participant ceases to be a director, officer or employee of, or to otherwise perform services for, the Company or any Subsidiary due to termination for
Cause such participant shall immediately forfeit any deferred stock units which would have matured or been earned at the end of the applicable Deferral Period. 
 Except as otherwise provided by the Committee, in the event of a Change in Control that also constitutes a “change in the ownership or effective control of” the Company, or a change in the
ownership of a substantial portion of the Company’s assets (in each case as determined under regulations issued pursuant to Section 409A(a)(2)(A)(v) of the Code), a participant shall receive payment in Shares in respect of such
participant’s deferred stock units which would have matured or been earned at the end of the applicable Deferral Period as if such Deferral Period had ended immediately prior to the Change in Control; provided, however, that if an event that
constitutes a Change in Control hereunder does not constitute a “change in control” under Section 409A of the Code (or the regulations promulgated thereunder), no payments with respect to the deferred stock units shall be made under
this paragraph to the extent such payments would constitute an impermissible acceleration under Section 409A of the Code. 
 9.
Performance Awards. 
 Performance awards may be granted to participants at any time and from time to time as
determined by the Committee. The Committee shall have complete discretion in determining the size and composition of performance awards granted to a participant. The period over which performance is to be measured (a “performance cycle”)
shall commence on the date specified by 

  
 11 

 
the Committee and shall end on the last day of a fiscal year specified by the Committee. A performance award shall be paid no later than the 15th day of the third month following the completion
of a performance cycle. Performance awards may include (i) specific dollar-value target awards (ii) performance units, the value of each such unit being determined by the Committee at the time of issuance, and/or (iii) performance
Shares, the value of each such Share being equal to the Fair Market Value of a share of Common Stock. 
 The value of each
performance award may be fixed or it may be permitted to fluctuate based on a performance factor (e.g., return on equity) selected by the Committee. 
 The Committee shall establish performance goals and objectives for each performance cycle on the basis of such criteria and objectives as the Committee may select from time to time, including, without
limitation, the performance of the participant, the Company, one or more of its Subsidiaries or divisions or any combination of the foregoing; provided that any Shares issued or issuable under performance awards with restrictions that have a
duration of less than one year will constitute Excluded Shares. During any performance cycle, the Committee shall have the authority to adjust the performance goals and objectives for such cycle for such reasons as it deems equitable. 

The Committee shall determine the portion of each performance award that is earned by a participant on the basis of the Company’s
performance over the performance cycle in relation to the performance goals for such cycle. The earned portion of a performance award may be paid out in Shares, cash, Other Company Securities, or any combination thereof, as the Committee may
determine. 
 A participant must be a director, officer or employee of, or otherwise perform services for, the Company or its
Subsidiaries at the end of the performance cycle in order to be entitled to payment of a performance award issued in respect of such cycle; provided, however, that except as otherwise determined by the Committee, if a participant ceases to be a
director, officer or employee of, or to otherwise perform services for, the Company and its Subsidiaries upon his or her death, Disability or Retirement prior to the end of the performance cycle, the participant shall earn a proportionate portion of
the performance award based upon the elapsed portion of the performance cycle and the Company’s performance over that portion of such cycle. 
 In the event of a Change in Control, a participant shall earn no less than the portion of the performance award that the participant would have earned if the applicable performance cycle(s) had terminated
as of the date of the Change in Control. 
 10. Withholding Taxes. 

(a) Participant Election. Unless otherwise determined by the Committee, a participant may elect to deliver shares of Common Stock
(or have the Company withhold shares acquired upon exercise of an option or deliverable upon grant or vesting of restricted stock, as the case may be) to satisfy, in whole or in part, the amount the Company is required to withhold for taxes in
connection with the exercise of an option or the delivery of restricted stock upon grant or vesting, as the case may be. Such election must be made on or before the date the amount of tax to be withheld is determined. Once made, the election shall
be irrevocable. The fair market value 

  
 12 

 
of the shares to be withheld or delivered will be the Fair Market Value as of the date the amount of tax to be withheld is determined. In the event a participant elects to deliver or have the
Company withhold shares of Common Stock pursuant to this Section 10(a), such delivery or withholding must be made subject to the conditions and pursuant to the procedures set forth in Section 6(b) with respect to the delivery or
withholding of Common Stock in payment of the exercise price of options. 
 (b) Company Requirement. The Company may
require, as a condition to any grant or exercise under the Plan or to the delivery of certificates for Shares issued hereunder, that the grantee make provision for the payment to the Company, either pursuant to Section 10(a) or this
Section 10(b), of federal, state or local taxes of any kind required by law to be withheld with respect to any grant or delivery of Shares. The Company, to the extent permitted or required by law, shall have the right to deduct from any payment
of any kind (including salary or bonus) otherwise due to a grantee, an amount equal to any federal, state or local taxes of any kind required by law to be withheld with respect to any grant or delivery of Shares under the Plan. 

11. Written Agreement; Vesting. 
 Unless the Committee determines otherwise, each employee to whom a grant is made under the Plan shall enter into a written agreement with the Company that shall contain such provisions, including without
limitation vesting requirements, consistent with the provisions of the Plan, as may be approved by the Committee. Unless the Committee determines otherwise and except as otherwise provided in Sections 6, 7, 8 and 9 in connection with a Change in
Control or certain occurrences of termination, no grant under this Plan may be exercised, and no restrictions relating thereto may lapse, within six months of the date such grant is made. 
 12. Transferability. 
 Unless the Committee determines otherwise, no
award granted under the Plan shall be transferable by a participant other than by will or the laws of descent and distribution or to a participant’s Family Member by gift or a qualified domestic relations order as defined by the Code. Unless
the Committee determines otherwise, an option may be exercised only by the optionee or grantee thereof; by his or her Family Member if such person has acquired the option by gift or qualified domestic relations order; by the executor or
administrator of the estate of any of the foregoing or any person to whom the option is transferred by will or the laws of descent and distribution; or by the guardian or legal representative of any of the foregoing; provided that Incentive Stock
Options may be exercised by any Family Member, guardian or legal representative only if permitted by the Code and any regulations thereunder. All provisions of this Plan shall in any event continue to apply to any award granted under the Plan and
transferred as permitted by this Section 12, and any transferee of any such award shall be bound by all provisions of this Plan as and to the same extent as the applicable original grantee. 

13. Listing, Registration and Qualification. 
 If the Committee determines that the listing, registration or qualification upon any securities exchange or under any law of Shares subject to any option, performance award, restricted stock unit,
deferred stock unit or restricted stock grant is necessary or desirable as a 

  
 13 

 
condition of, or in connection with, the granting of same or the issue or purchase of Shares thereunder, no such option may be exercised in whole or in part, no such performance award may be paid
out, and no Shares may be issued, unless such listing, registration or qualification is effected free of any conditions not acceptable to the Committee. 
 14. Transfer of Employee. 
 The transfer of an employee from the
Company to a Subsidiary, from a Subsidiary to the Company, or from one Subsidiary to another shall not be considered a termination of employment; nor shall it be considered a termination of employment if an employee is placed on military or sick
leave or such other leave of absence which is considered by the Committee as continuing intact the employment relationship. 
 15.
Adjustments. 
 In the event of a reorganization, recapitalization, stock split, stock dividend, combination of
shares, merger, consolidation, distribution of assets, or any other change in the corporate structure or shares of the Company, the Committee shall make such adjustment as it deems appropriate in the number and kind of Shares or other property
available for issuance under the Plan (including, without limitation, the total number of Shares available for issuance under the Plan pursuant to Section 4), in the number and kind of options, Shares, restricted stock units, deferred stock
units or other property covered by grants previously made under the Plan, and in the exercise price of outstanding options. Any such adjustment shall be final, conclusive and binding for all purposes of the Plan. In the event of any merger,
consolidation or other reorganization in which the Company is not the surviving or continuing corporation or in which a Change in Control is to occur, all of the Company’s obligations regarding awards that were granted hereunder and that are
outstanding on the date of such event shall, on such terms as may be approved by the Committee prior to such event, be (a) canceled in exchange for cash or other property (but, with respect to vested deferred stock units, only if such merger,
consolidation, other reorganization, or Change in Control constitutes a “change in ownership or control” of the Company or a “change in the ownership of a substantial portion” of the Company’s assets, as determined pursuant
to regulations issued under Section 409A(a)(2)(A)(v) of the Code) or (b) assumed by the surviving or continuing corporation. 
 Without limitation of the foregoing, in connection with any transaction of the type specified by clause (iii) of the definition of a Change in Control in Section 2(c), the Committee may, in its
discretion, (i) cancel any or all outstanding options under the Plan in consideration for payment to the holders thereof of an amount equal to the portion of the consideration that would have been payable to such holders pursuant to such
transaction if their options had been fully exercised immediately prior to such transaction, less the aggregate exercise price that would have been payable therefor, or (ii) if the amount that would have been payable to the option holders
pursuant to such transaction if their options had been fully exercised immediately prior thereto would be equal to or less than the aggregate exercise price that would have been payable therefor, cancel any or all such options for no consideration
or payment of any kind. Payment of any amount payable pursuant to the preceding sentence may be made in cash or, in the event that the consideration to be received in such transaction includes securities or other property, in cash and/or securities
or other property in the Committee’s discretion. 

  
 14 

 16. Amendment and Termination of the Plan. 

The Board of Directors or the Committee, without approval of the stockholders, may amend or terminate the Plan, except that no amendment
shall become effective without prior approval of the stockholders of the Company if stockholder approval would be required by applicable law or regulations or by any listing requirement of the principal stock exchange on which the Common Stock is
then listed. 
 17. Amendment or Substitution of Awards under the Plan. 

The terms of any outstanding award under the Plan may be amended from time to time by the Committee in its discretion in any manner that
it deems appropriate, including, but not limited to, acceleration of the date of exercise of any award and/or payments thereunder or of the date of lapse of restrictions on Shares (but only to the extent permitted by regulations issued under
Section 409A(a)(3) of the Code); provided that, except as otherwise provided in Section 15, no such amendment shall adversely affect in a material manner any right of a participant under the award without his or her written consent, and
provided further that the Committee shall not reduce the exercise price of any options awarded under the Plan without approval of the stockholders of the Company. The Committee may, in its discretion, permit holders of awards under the Plan to
surrender outstanding awards in order to exercise or realize rights under other awards, but only if such surrender, exercise or realization (a) would not constitute a distribution of deferred compensation for purposes of Section 409A(a)(3)
of the Code or (b) constitutes a distribution of deferred compensation that is permitted under regulations issued pursuant to Section 409A(a)(3) of the Code. Notwithstanding the foregoing, the Committee may only lapse or waive restrictions
on the exercisability or vesting of any awards under the Plan in cases relating to death, Disability, Retirement or Change in Control. If the Committee discretionarily accelerates restrictions on the exercisability or vesting of any awards under the
Plan, except in cases relating to death, Disability, Retirement or Change in Control, any shares issued or issuable under such awards will constitute Excluded Shares. 
 18. Commencement Date; Termination Date. 
 The date of commencement
of the Plan was August 8, 2005, the date on which the Company’s Registration Statement on Form S-1 (File No. 333-124285) was declared effective by the Securities and Exchange Commission. 

Unless previously terminated upon the adoption of a resolution of the Board terminating the Plan, the Plan shall terminate at the close
of business on, August 8, 2015, the ten year anniversary of the date of commencement. No termination of the Plan shall materially and adversely affect any of the rights or obligations of any person, without his or her written consent, under any
grant of options or other incentives theretofore granted under the Plan. 
 19. Severability. 

Whenever possible, each provision of the Plan shall be interpreted in such manner as to be effective and valid under applicable law, but
if any provision of the Plan is held to be prohibited by or invalid under applicable law, such provision shall be ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder of the Plan. 

  
 15 

 20. Governing Law. 
 The Plan shall be governed by the corporate laws of the State of Delaware, without giving effect to any choice of law provisions that might otherwise refer construction or interpretation of the Plan to
the substantive law of another jurisdiction. 

  
 16Amendment No. 1 to Note Purchase Agreement

 Exhibit 4.1 
 Execution Version 
 AMENDMENT NO. 1 TO NOTE PURCHASE AGREEMENT

 This AMENDMENT NO. 1 TO NOTE PURCHASE AGREEMENT (this “Agreement”) is made as of
October 26, 2012 by and among AMEDISYS, INC., a Delaware corporation (the “Company”), and AMEDISYS HOLDING, L.L.C., a Louisiana limited liability company (“Holding”; and together with the Company,
the “Issuers”), and the holders of Notes (as defined below) signatory hereto (the “Noteholders”). 
 WHEREAS, the Issuers and the Noteholders are parties to that certain Note Purchase Agreement, dated March 25, 2008 (the “Existing Note Purchase Agreement”; and as amended by
this Agreement and as may be further amended, restated, supplemented or otherwise modified from time to time, the “Note Purchase Agreement”); 
 WHEREAS, pursuant to the Existing Note Purchase Agreement, the Issuers issued and sold to the Noteholders (a) $35,000,000 aggregate principal amount of their 6.07% Series A Senior Notes due
March 25, 2013 (the “Existing Series A Notes”), (b) $30,000,000 aggregate principal amount of their 6.28% Series B Senior Notes due March 25, 2014 (the “Existing Series B Notes” and together with the
Existing Series A Notes, the “Existing Notes”; and as amended by this Agreement and as may be further amended, restated, supplemented or otherwise modified from time to time, the “Notes”) and (c) $35,000,000
aggregate principal amount of their 6.49% Series C Senior Notes due March 25, 2015, such Series C Senior Notes have been repaid and are no longer outstanding; and 
 WHEREAS, the Issuers desire to amend certain provisions of the Existing Note Purchase Agreement, and the Noteholders have agreed to make such amendments, subject to the terms and conditions set
forth in this Agreement. 
 NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is
hereby acknowledged, the parties hereto agree as follows: 
 1. DEFINED TERMS. 

Capitalized terms used and not defined herein (or in any exhibit, annex or schedule attached hereto) shall have the same meanings given to
them in the Note Purchase Agreement. 
 2. REPRESENTATIONS AND WARRANTIES. 

To induce the Noteholders to enter into this Agreement, the Issuers represent and warrant to each of the Noteholders as follows (it being
agreed, however, that nothing in this Section 2 shall affect any of the representations and warranties previously made by the Issuers in or pursuant to the Note Purchase Agreement, and that all of such other representations and warranties, as
well as the representations and warranties in this Section 2, shall survive the effectiveness of the Amendments). 

2.1. Organization; Authority and Good Standing. 
 The Company is a corporation, and Holding is a limited liability company, each duly organized, validly existing and in good standing under the laws of its respective jurisdiction of organization. Each
Issuer has the organizational power and authority to execute and deliver this Agreement and to perform the provisions hereof. 

  
 -1-

 2.2. Authorization, etc. 

This Agreement has been duly authorized by all necessary organizational action on the part of each Issuer and this Agreement constitutes a
legal, valid and binding obligation of each Issuer enforceable against such Issuer in accordance with its terms, except as such enforceability may be limited by (a) applicable bankruptcy, insolvency, reorganization, moratorium or other similar
laws affecting the enforcement of creditors’ rights generally and (b) general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law). 

2.3. Compliance with Laws, Other Instruments, etc. 
 The execution, delivery and performance by each Issuer of this Agreement will not: (a) contravene, result in any breach of, or constitute a default under, or result in the creation of any Lien in
respect of any property of either Issuer or any Subsidiary under, any indenture, mortgage, deed of trust, loan, purchase or credit agreement, lease, corporate charter, memorandum and articles of association, regulations or by-laws, or other
agreement or instrument to which either Issuer or any Subsidiary is bound or by which either Issuer or any Subsidiary or any of their respective properties may be bound or affected (other than Liens in favor of the holders of the Notes as
contemplated in the Note Purchase Agreement (as amended by this Agreement) and in favor of the administrative agent pursuant to the Credit Agreement (as defined below)), (b) conflict with or result in a breach of any of the terms, conditions or
provisions of any order, judgment, decree, or ruling of any court, arbitrator or Governmental Authority applicable to either Issuer or any Subsidiary, or (c) violate any provision of any statute or other rule or regulation of any Governmental
Authority applicable to either Issuer or any Subsidiary. 
 2.4. Governmental Action. 

No consent, approval or authorization of, or registration, filing or declaration with, any Governmental Authority is required in
connection with the execution, delivery or performance by either Issuer of this Agreement. 
 2.5. No Defaults.

 No event has occurred and is continuing which constitutes a Default or an Event of Default under the Note Purchase
Agreement. 
 3. EFFECTIVENESS. 
 The Amendments (as defined below) shall become effective, and shall be deemed to be in effect, upon the satisfaction in full of the following conditions (the “Amendments Effective Date”):

 (a) This Agreement. Each Issuer and each Noteholder shall have executed and delivered this Agreement.

  
 -2-

 (b) Credit Agreement. 

 

	 	(i)	The Issuers shall have executed that certain Credit Agreement dated as of the date hereof among Issuers, JPMorgan Chase Bank, N.A., as administrative agent, and certain
other agents and lenders party thereto, and shall have established pursuant thereto a senior unsecured credit facility providing for (A) a $165,000,000 revolving credit facility and (B) a $60,000,000 term loan (the “Credit
Agreement”). 

  

	 	(ii)	The terms and conditions of the Credit Agreement shall be reasonably satisfactory to the Noteholders. 

 

	 	(iii)	The Issuers shall have delivered certified copies of the Credit Agreement to the Noteholders. 

(c) Waiver No. 1 to Note Purchase Agreement. The Issuers shall have entered into that certain Waiver
No. 1 to Note Purchase Agreement with the Teachers Noteholder, the Guardian Noteholder and the Prudential Noteholders (each as defined therein) dated on or about October 26, 2012 and the Notes held by the Teachers Noteholder and Guardian
Noteholder shall have been paid in full in accordance with the terms of such Waiver No. 1 to Note Purchase Agreement. 
 (d) Representations. The representations and warranties of the Issuers made in Section 2 of this Agreement shall be true and correct as of the Amendment Effective Date in all respects.

 (e) Fees and Expenses. The Issuers shall have paid (i) an amendment fee by wire transfer of
immediately available funds (in accordance with the wiring instructions for payments under the Note Purchase Agreement) in an aggregate amount equal to $300,000, such amendment fee to be allocated among the Noteholders pro rata based on the
principal amount of Notes held by each such Noteholder and (ii) the reasonable fees and expenses of the special counsel to the Noteholders as provided for in Section 6 herein. 
 4. AMENDMENTS TO EXISTING NOTE PURCHASE AGREEMENT. 
 Subject to satisfaction
of the conditions set forth in Section 3, the Existing Note Purchase Agreement is hereby amended as provided in Exhibit A attached hereto (such amendments being collectively referred to herein as the “Note Purchase Agreement
Amendments”). 
 5. AMENDMENTS TO EXISTING NOTES. 
 Subject to satisfaction of the conditions set forth in Section 3, the Existing Series A Notes and Existing Series B Notes are hereby, without any further action required on the part of any other
Person, deemed to be automatically amended to conform to and have the terms provided in Exhibit B and Exhibit C, as applicable, attached hereto (except that the principal amount, the date and the payee of each Note shall remain
unchanged). Any Note issued on or after the date hereof shall be in the form of Exhibit B attached hereto. The term “Notes” as used in the Note 

  
 -3-

 
Purchase Agreement shall include each Note delivered pursuant to any provision of the Note Purchase Agreement, as amended hereby (and as hereafter amended) and each Note delivered in substitution
or exchange for any such Note pursuant to any such provision. Upon request of any holder of a Note, the Issuers will issue a replacement Note or Notes in the form attached hereto as Exhibit B or Exhibit C, as applicable, in favor of such
holder’s existing Note or existing Notes. 
 The amendments specified in this Section 5 are referred to herein as the
“Note Amendments” and the Note Amendments and the Note Purchase Agreement Amendments are referred to herein as the “Amendments”. 
 6. EXPENSES. 
 The Issuers will promptly (and in any event within thirty
days of receiving any statement or invoice therefor) pay all out-of-pocket fees, expenses and costs relating to this Agreement, including, but not limited to, the reasonable fees of special counsel to the Noteholders incurred in connection with the
preparation, negotiation and delivery of this Agreement and any other documents related hereto. Nothing in this Section 6 shall limit the Issuers’ obligations under Section 15.1 of the Note Purchase Agreement. 

7. MISCELLANEOUS. 

7.1. Part of Existing Note Purchase Agreement; Future References, etc. 

This Agreement shall be construed in connection with and as a part of the Note Purchase Agreement and, except as expressly amended by this
Agreement, all terms, conditions and covenants contained in the Existing Note Purchase Agreement and each other Financing Document are hereby ratified and shall be and remain in full force and effect. Any and all notices, requests, certificates and
other instruments executed and delivered after the execution and delivery of this Agreement may refer to the Note Purchase Agreement without making specific reference to this Agreement, but nevertheless all such references shall include this
Agreement unless the context otherwise requires. This Agreement shall constitute a Financing Document under the terms of the Note Purchase Agreement. 
 7.2. Counterparts, Facsimiles. 
 This Agreement may be executed in any
number of counterparts, each of which shall be an original but all of which together shall constitute one instrument. Each counterpart may consist of a number of copies hereof, each signed by less than all, but together signed by all, of the parties
hereto. Delivery of an executed signature page by facsimile or e-mail transmission shall be effective as delivery of a manually signed counterpart of this Agreement. 
 7.3. Severability. 
 Any provision of this Agreement which is prohibited or
unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining portions hereof or affecting the validity or enforceability of such provisions
in any other jurisdiction. 

  
 -4-

 7.4. Binding Effect. 

This Agreement shall be binding upon and shall inure to the benefit of each Issuer and the Noteholders and their respective successors and
assigns. 
 7.5. Governing Law. 
 THIS AGREEMENT SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, AND THE RIGHTS OF THE PARTIES SHALL BE GOVERNED BY, THE LAW OF THE STATE OF NEW YORK EXCLUDING CHOICE-OF-LAW PRINCIPLES OF THE LAW OF
SUCH STATE THAT WOULD PERMIT THE APPLICATION OF THE LAWS OF A JURISDICTION OTHER THAN SUCH STATE. 
 [Remainder of page
intentionally left blank.] 

  
 -5-

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed
and delivered by their respective proper and duly authorized officers as of the day and year first above written. 
  

			
	AMEDISYS, INC.
		
	 By:
	 	 /s/ Ronald A. LaBorde

	 Name: Ronald A. LaBorde

	 Title: President and Chief Financial Officer

	
	AMEDISYS HOLDING, L.L.C.
		
	 By:
	 	 /s/ Ronald A. LaBorde

	 Name: Ronald A. LaBorde

	 Title: Vice-President

  
 [Signature
Page to Amendment No. 1 to Note Purchase Agreement (Amedisys)] 

			
	NOTEHOLDERS:
	
	 THE PRUDENTIAL INSURANCE COMPANY
 OF AMERICA

		
	By: 	 	/s/ Brien Davis
	Name: Brien Davis
	Title: Vice President

  

					
	PRUDENTIAL RETIREMENT INSURANCE
	AND ANNUITY COMPANY
		
	By:	 	Prudential Investment Management, Inc.,
		 	as investment manager
			
		 	By:	 	/s/ Brien Davis
		 	Name: Brien Davis
		 	Title: Vice President

  

					
	PHYSICIANS MUTUAL INSURANCE COMPANY
		
	By:	 	Prudential Private Placement Investors,
		 	L.P. (as Investment Advisor)
			
		 	By:	 	Prudential Private Placement Investors, Inc.
		 		 	(as its General Partner)
			
		 	By:	 	/s/ Brien Davis
		 	Name: Brien Davis
		 	Title: Vice President

  
 [Signature
Page to Amendment No. 1 to Note Purchase Agreement (Amedisys)] 

 Acknowledgment and Agreement 

Each of the undersigned Subsidiary Guarantors acknowledges and accepts the foregoing Agreement and ratifies and confirms in all respects
such Subsidiary Guarantor’s obligations under the Subsidiary Guaranty: 
  

	
	 ACCUMED GENPAR, L.L.C.

	 ACCUMED HOLDING CORP.

	 ACCUMED HOME HEALTH OF GEORGIA, INC.

	 ACCUMED HOME HEALTH OF NORTH TEXAS, L.L.C.

	 ADVENTA HOSPICE SERVICES OF
FLORIDA, INC.

	 ADVENTA HOSPICE, INC.

	 ALBERT GALLATIN HOME CARE AND
HOSPICE SERVICES, LLC

	 AMEDISYS AIR, L.L.C.

	 AMEDISYS ALASKA, LLC

	 AMEDISYS ARIZONA, L.L.C.

	 AMEDISYS ARKANSAS, LLC

	 AMEDISYS BA, LLC

	 AMEDISYS CALIFORNIA, L.L.C.

	 AMEDISYS COLORADO, L.L.C.

	 AMEDISYS CONNECTICUT, L.L.C.

	 AMEDISYS DELAWARE, L.L.C.

	 AMEDISYS EQUITY GROUP, L.L.C.

	 AMEDISYS FLORIDA, L.L.C.

	 AMEDISYS GEORGIA, L.L.C.

	 AMEDISYS HEALTH MANAGEMENT, L.L.C.

	 AMEDISYS HMA ACQUISITION, L.L.C.

	 AMEDISYS HOME HEALTH, INC. OF
ALABAMA

	 AMEDISYS HOME HEALTH, INC. OF SOUTH CAROLINA

	 AMEDISYS HOME HEALTH, INC. OF
VIRGINIA

	 AMEDISYS HOSPICE, L.L.C.

	 AMEDISYS IDAHO, L.L.C.

	 AMEDISYS ILLINOIS, L.L.C.

	 AMEDISYS INDIANA, L.L.C.

	 AMEDISYS IOWA, L.L.C.

	 AMEDISYS KANSAS, L.L.C.

	 AMEDISYS LA ACQUISITIONS, L.L.C.

	 AMEDISYS LOUISIANA, L.L.C.

	 AMEDISYS MAINE, P.L.L.C.

	 AMEDISYS MARYLAND, L.L.C.

	 AMEDISYS MASSACHUSETTS, L.L.C.

	 AMEDISYS MICHIGAN, L.L.C.

  
 [Signature
Page to Amendment No. 1 to Note Purchase Agreement (Amedisys)] 

	
	 AMEDISYS MINNESOTA, L.L.C.

	 AMEDISYS MISSISSIPPI, L.L.C.

	 AMEDISYS MISSOURI, L.L.C.

	 AMEDISYS NEBRASKA, L.L.C.

	 AMEDISYS NEVADA, L.L.C.

	 AMEDISYS NEW HAMPSHIRE, L.L.C.

	 AMEDISYS NEW JERSEY, L.L.C.

	 AMEDISYS NEW MEXICO, L.L.C.

	 AMEDISYS NORTH CAROLINA, L.L.C.

	 AMEDISYS NORTH DAKOTA, L.L.C.

	 AMEDISYS NORTHWEST, L.L.C.

	 AMEDISYS OHIO, L.L.C.

	 AMEDISYS OKLAHOMA, L.L.C.

	 AMEDISYS OREGON, L.L.C.

	 AMEDISYS PENNSYLVANIA, L.L.C.

	 AMEDISYS PRIVATE DUTY, LLC

	 AMEDISYS PROPERTY, L.L.C.

	 AMEDISYS PUERTO RICO, L.L.C.

	 AMEDISYS QUALITY OKLAHOMA, L.L.C.

	 AMEDISYS RHODE ISLAND, L.L.C.

	 AMEDISYS SC, L.L.C.

	 AMEDISYS SOUTH FLORIDA, L.L.C.

	 AMEDISYS SOUTH DAKOTA, L.L.C.

	 AMEDISYS SPECIALIZED MEDICAL
SERVICES, L.L.C.

	 AMEDISYS SP-IN, L.L.C.

	 AMEDISYS SP-KY, L.L.C.

	 AMEDISYS SP-OH, L.L.C.

	 AMEDISYS SP-TN, L.L.C.

	 AMEDISYS TENNESSEE, L.L.C.

	 AMEDISYS TEXAS, L.L.C.

	 AMEDISYS TLC ACQUISITION, L.L.C.

	 AMEDISYS UTAH, L.L.C.

	 AMEDISYS VENTURES, L.L.C.

	 AMEDISYS VIRGINIA, L.L.C.

	 AMEDISYS WASHINGTON, L.L.C.

	 AMEDISYS WEST VIRGINIA, L.L.C.

	 AMEDISYS WISCONSIN, L.L.C.

	 AMEDISYS WYOMING, L.L.C.

	 ARNICA THERAPY SERVICES, L.L.C.

	 AVENIR VENTURES, L.L.C.

	 BEACON HOSPICE, INC.

	 BEACON PALLIATIVE CARE SERVICES, INC.

	 BROOKSIDE HOME HEALTH, LLC

	 COMPREHENSIVE HOME HEALTHCARE
SERVICES, INC.

  
 [Signature
Page to Amendment No. 1 to Note Purchase Agreement (Amedisys)] 

	
	 EMERALD CARE, INC.

	 FAMILY HOME HEALTH CARE, INC.

	 GM VENTURES, LLC

	 HHC, L.L.C.

	 HMA HOLDING, INC.

	 HMR ACQUISITION, INC.

	 HOME HEALTH OF ALEXANDRIA, L.L.C.

	 HORIZONS HOSPICE CARE, INC.

	 HOUSECALL HOME HEALTH, L.L.C.

	 HOUSECALL MEDICAL RESOURCES, INC.

	 HOUSECALL MEDICAL SERVICES, L.L.C.

	 HOUSECALL SUPPORTIVE SERVICES, L.L.C.

	 HOUSECALL, L.L.C.

	 M.M. ACCUMED VENTURES, L.L.C.

	 M2 VENTURES, L.L.C.

	 MC VENTURES, LLC

	 TENDER LOVING CARE HEALTH CARE
SERVICES INTERNATIONAL, LLC

	 TENDER LOVING CARE HEALTH CARE
SERVICES MIDWEST, LLC

	 TENDER LOVING CARE HEALTH CARE
SERVICES OF BROWARD, LLC

	 TENDER LOVING CARE HEALTH CARE
SERVICES OF DADE, LLC

	 TENDER LOVING CARE HEALTH CARE
SERVICES OF ERIE NIAGARA, LLC

	 TENDER LOVING CARE HEALTH CARE
SERVICES OF FLORIDA, LLC

	 TENDER LOVING CARE HEALTH CARE
SERVICES OF GEORGIA, LLC

	 TENDER LOVING CARE HEALTH CARE
SERVICES OF ILLINOIS, LLC

	 TENDER LOVING CARE HEALTH CARE
SERVICES OF LONG ISLAND, LLC

	 TENDER LOVING CARE HEALTH CARE
SERVICES OF MICHIGAN, LLC

	 TENDER LOVING CARE HEALTH CARE
SERVICES OF NASSAU SUFFOLK, LLC

	 TENDER LOVING CARE HEALTH CARE
SERVICES OF NEW ENGLAND, LLC

	 TENDER LOVING CARE HEALTH CARE
SERVICES OF PA, LLC

	 TENDER LOVING CARE HEALTH CARE
SERVICES OF WEST VIRGINIA, LLC

	 TENDER LOVING CARE HEALTH CARE
SERVICES OF WESTERN NEW YORK, LLC

  
 [Signature
Page to Amendment No. 1 to Note Purchase Agreement (Amedisys)] 

	
	 TENDER LOVING CARE HEALTH CARE
SERVICES SOUTHEAST, LLC

	 TENDER LOVING CARE HEALTH CARE
SERVICES WESTERN, LLC

	 TLC HEALTH CARE SERVICES, INC.

	 TLC HOLDINGS I CORP.

  

			
	By:	 	/s/ Ronald A. LaBorde
	Name: Ronald A. LaBorde
	Title: Vice-President

  
 [Signature
Page to Amendment No. 1 to Note Purchase Agreement (Amedisys)] 

					
	ACCUMED HEALTH SERVICES, L.P.
		
	By:	 	ACCUMED GENPAR, L.L.C.,
	General Partner
			
		 	By:	 	/s/ Ronald A. LaBorde
		 	Name: Ronald A. LaBorde
		 	Title: Vice-President

  

					
	NINE PALMS 1, LP
		
	By:	 	 BROOKSIDE HOME HEALTH, LLC,
 General Partner

			
		 	By:	 	/s/ Ronald A. LaBorde
		 	Name: Ronald A. LaBorde
		 	Title: Vice-President

  

					
	NINE PALMS 2, LLP
		
	By:	 	MC VENTURES, LLC, General Partner
			
		 	By:	 	/s/ Ronald A. LaBorde
		 	Name: Ronald A. LaBorde
		 	Title: Vice-President

  
 [Signature
Page to Amendment No. 1 to Note Purchase Agreement (Amedisys)] 

 EXHIBIT A 

AMENDMENTS TO NOTE PURCHASE AGREEMENT 
  

	 	1.	Section 7.1(a) of the Existing Note Purchase Agreement is hereby amended by amending and restating clauses (i) and (ii) therein to read as follows:

 “(i) a consolidated balance sheet of the Company and its Subsidiaries as at the end of such quarter
(including consolidating statements on a summary basis for the Subsidiaries of the Issuers distinguishing among Subsidiaries that are Wholly-Owned Subsidiaries, not Wholly-Owned Subsidiaries, Subsidiary Guarantors and not Subsidiary Guarantors), and

 (ii) consolidated statements of income, changes in shareholders’ equity and cash flows of the Company and its
Subsidiaries, for such quarter and (in the case of the second and third quarters) for the portion of the fiscal year ending with such quarter (including, in each case, consolidating statements on a summary basis for the Subsidiaries of the Issuers
distinguishing among Subsidiaries that are Wholly-Owned Subsidiaries, not Wholly-Owned Subsidiaries, Subsidiary Guarantors and not Subsidiary Guarantors),” 
  

	 	2.	Section 7.1(b) of the Existing Note Purchase Agreement is hereby amended by amending and restating clauses (i) and (ii) therein to read as follows:

 “(i) a consolidated balance sheet of the Company and its Subsidiaries as at the end of such year (including
consolidating statements, audited or unaudited, as may be available, on a summary basis for the Subsidiaries of the Issuers distinguishing among Subsidiaries that are Wholly-Owned Subsidiaries, not Wholly-Owned Subsidiaries, Subsidiary Guarantors
and not Subsidiary Guarantors), and 
 (ii) consolidated statements of income, changes in shareholders’ equity and cash
flows of the Company and its Subsidiaries for such year (including, in each case, consolidating statements, audited or unaudited, as may be available, on a summary basis for the Subsidiaries of the Issuers distinguishing among Subsidiaries that are
Wholly-Owned Subsidiaries, not Wholly-Owned Subsidiaries, Subsidiary Guarantors and not Subsidiary Guarantors),” 
  

	 	3.	Section 7.2(c) of the Existing Note Purchase Agreement is hereby amended and restated in its entirety to read as follows: 

“(c) Subsidiary Guarantors — a list of all Subsidiary Guarantors (or a statement that the list of Subsidiary Guarantors
most recently delivered pursuant to this Section 7.2 remains unchanged).” 
  

	 	4.	Section 7.2 of the Existing Note Purchase Agreement is hereby amended by adding a new paragraph (d) therein to read as follows: 

  
 Exhibit A-1

 “(d) Additional Covenant Information — the information required to be
delivered pursuant to Section 9.8(b) and 10.7(c)(v).” 
  

	 	5.	Section 8.6 of the Existing Note Purchase Agreement is hereby amended by deleting the last sentence of the definition of “Remaining Scheduled Payments”.

  

	 	6.	Section 8.7 of the Existing Note Purchase Agreement is hereby amended and restated in its entirety to read as follows: 

“8.7 [Intentionally omitted].” 
  

	 	7.	Section 8.8 of the Existing Note Purchase Agreement is hereby amended by amending and restating the definition of “Change of Control” therein as follows:

 “A “Change of Control” means at any time, (a) any Person or “group” (within
the meaning of Rules 13d-3 and 13d-5 under the Exchange Act) (i) shall have acquired beneficial ownership of 35% or more on a fully diluted basis of the voting and/or economic interest in the Capital Stock of the Company or (ii) shall have
obtained the power (whether or not exercised) to elect a majority of the members of the Board of Directors of the Company, (b) the majority of the seats (other than vacant seats) on the Board of Directors of the Company cease to be occupied by
Persons who are Continuing Directors or (c) a “Change of Control” as defined in the Credit Agreement.” 
  

	 	8.	Section 9.5 of the Existing Note Purchase Agreement is hereby amended and restated in its entirety to read as follows: 

“9.5 Corporate Existence. Each Issuer will at all times preserve and keep in full force and effect its corporate existence.
Subject to Section 10.6, each Issuer will at all times preserve and keep in full force and effect the corporate existence of each of its Subsidiaries and all rights and franchises of each Issuer and its Subsidiaries unless, in the good faith
judgment of such Issuer, the termination of or failure to preserve and keep in full force and effect such corporate existence, right or franchise could not, individually or in the aggregate, have a Material Adverse Effect.” 

 

	 	9.	Section 9.8 of the Existing Note Purchase Agreement is hereby amended and restated in its entirety to read as follows: 

“9.8 Subsidiary Guarantors. 
 (a) The Issuers shall cause each Significant Subsidiary (each, an “Original Subsidiary Guarantor”) to execute and deliver, on or before Closing, the Subsidiary Guaranty. In addition to
the foregoing, the Issuers will at all times provide Guaranty Joinder Agreements (and the documents described in clause (b)(ii) below) from (i) their Wholly-Owned Subsidiaries such that for the most recently ended trailing four fiscal quarter
period (A) the Consolidated Adjusted EBITDA that is attributable only to the Wholly-Owned Subsidiaries that are Subsidiary Guarantors is not less than 95% of the Consolidated Adjusted EBITDA that is attributable to all of the Company’s
Wholly-Owned Subsidiaries and (B) the aggregate Net Revenues of the Wholly-Owned Subsidiaries that are Subsidiary Guarantors (excluding any contribution to Net 

  
 Exhibit A-2

 
Revenues from Subsidiaries that are not Wholly-Owned Subsidiaries) do not constitute less than 95% of the aggregate Net Revenues of all of the Wholly-Owned Subsidiaries of the Company (excluding
any contribution to Net Revenues from Subsidiaries that are not Wholly-Owned Subsidiaries) and (ii) any other Subsidiary that is a guarantor or borrower of Indebtedness outstanding under the Credit Agreement. In addition to the foregoing, the
Issuers will at all times provide Guaranty Joinder Agreements from their Subsidiaries such that for the most recently ended trailing four fiscal quarter period the Consolidated Adjusted EBITDA that is attributable only to the Subsidiary Guarantors
is not less than 70% of Consolidated Adjusted EBITDA. Notwithstanding the immediately preceding sentence, if the Company complies with Section 9.9, the Issuers will at all times provide Guaranty Joinder Agreements from their Subsidiaries such
that for the most recently ended trailing four fiscal quarter period the Consolidated Adjusted EBITDA that is attributable only to the Subsidiary Guarantors is not less than 60% (rather than 70%) of Consolidated Adjusted EBITDA. 

(b) Within thirty days after the Issuers create or acquire a new Subsidiary that is required to be a Subsidiary Guarantor pursuant to
paragraph (a) above, the Issuers shall (i) cause such new Subsidiary to become a Subsidiary Guarantor by executing and delivering to the holders of Notes a Guaranty Joinder Agreement promptly after acquisition or creation of such
Subsidiary, and (ii) deliver (A) a certificate of good standing (or equivalent) for such Subsidiary from its jurisdiction of organization and (B) such other documents and certificates as the Required Holders or their counsel may
reasonably request relating to the organization, existence and good standing of such Subsidiary, the authorization of the transactions contemplated hereby, the authority of any natural Person executing the Guaranty Joinder Agreement on behalf of
such Subsidiary and any other legal matters relating to such Subsidiary, this Agreement, the Guaranty Joinder Agreement or the transactions contemplated to occur hereby, all in form and substance reasonably satisfactory to the Required Holders and
their counsel. With respect to each new Subsidiary, whether or not such Subsidiary is required to provide a Guaranty Joinder Agreement pursuant to paragraph (a) above, the Issuers shall promptly send to the holders of Notes written notice
setting forth with respect to such Person (i) the date on which such Person became a Subsidiary of the Issuers and (ii) all of the data required to be set forth in Schedule 5.4 with respect to all Subsidiaries of the Issuers. 

 

	 	10.	Section 9 of the Existing Note Purchase Agreement is hereby amended by adding the following new Section 9.9 at the end thereof as follows:

 “9.9 Security. 
 As a condition to the 60% guarantee requirement described in the last sentence of Section 9.8(a), the Company shall pledge and shall cause each of its Wholly-Owned Subsidiaries to pledge, in each
case, as security for the Notes, all of their Capital Stock in (a) Subsidiaries created after the First Amendment Effective Date that are not Wholly-Owned Subsidiaries (excluding Immaterial Subsidiaries), (b) Wholly-Owned Subsidiaries that
own Capital Stock of Subsidiaries described in clause (a), (c) Persons created after the First Amendment Effective Date in which the Issuers or one or more Wholly-Owned Subsidiaries of the Issuers own 50% of the Capital Stock of such Person and
(d) Wholly-Owned Subsidiaries that own Capital Stock of the Persons described in clause (c), pursuant to the Security and Pledge Agreement. If Indebtedness under the 

  
 Exhibit A-3

 
Credit Agreement is then outstanding, the Company shall provide evidence satisfactory to the Required Holders that the administrative agent under the Credit Agreement has consented to the pledge
of such Capital Stock to secure the Notes (such consent to be pursuant to a written intercreditor agreement among the Issuers, the holders of Notes, and the administrative agent (on behalf of itself and the lenders under the Credit Agreement) in
form and substance satisfactory to the Required Holders, which agreement shall permit the pledge of such Capital Stock to secure the obligations under the Credit Agreement and the Notes on a pari passu basis). From and after the date on which the
Company complies with this Section 9.9, the Company shall and shall cause its Wholly-Owned Subsidiaries to, as applicable, within thirty (30) days after the acquisition or creation of any Subsidiary that is not a Wholly-Owned Subsidiary or
of any Person described in clause (c) above, (i) execute and deliver an addendum to the Security and Pledge Agreement covering the Capital Stock of such new Subsidiary or such new Person, as the case may be, and, if not previously pledged,
of the Wholly-Owned Subsidiary that owns such Capital Stock in such new Subsidiary or Person and (ii) deliver all other documents and certificates, including, if applicable, stock certificates and stock powers executed in blank, necessary to
perfect the holders’ Lien in such Capital Stock, as may be requested by the Required Holders.” 
  

	 	11.	Section 10.2 of the Existing Note Purchase Agreement is hereby amended and restated in its entirety to read as follows: 

“10.2 [Intentionally omitted].” 
  

	 	12.	Section 10.5 of the Existing Note Purchase Agreement is hereby amended by: 

 

	 	a.	amending and restating clause (g) in its entirety to read as follows: 

 “(g) [intentionally omitted];” 
  

	 	b.	deleting “and” at the end of clause (m) therein, (ii) amending and restating clause (n) therein as set forth below, (iii) replacing the
reference to clause “(n)” in the last paragraph thereof with “(q)”, and (iv) inserting the following new clauses (o), (p) and (q) therein to read as follows: 

“(n) Liens securing Indebtedness permitted under Section 10.12(m) not otherwise permitted by this Section so long as neither
(i) the aggregate outstanding principal amount of the obligations secured thereby nor (ii) the aggregate fair market value (determined as of the date such Lien is incurred) of the assets subject thereto exceeds (as to the Issuers and all
Subsidiaries) $10,000,000 at any time; 
 (o) Liens in favor of the holders of the Notes created by this Agreement and the
Security and Pledge Agreement; 
 (p) Liens in favor of the administrative agent and the lenders under the Credit Agreement as
permitted by the intercreditor agreement described in Section 9.9; and 

  
 Exhibit A-4

 (q) Liens on cash securing certain amounts of “Fronting Exposure” (as defined in
the Credit Agreement as in effect on the First Amendment Effective Date) in respect of Defaulting Lenders (as defined in the Credit Agreement as in effect on the First Amendment Effective Date) pursuant to Section 2.25 of the Credit Agreement
(as in effect on the First Amendment Effective Date).” 
  

	 	13.	Section 10.6 of the Existing Note Purchase Agreement is hereby amended and restated in its entirety to read as follows: 

“10.6 Sale of Assets. 
 Neither Issuer will, and neither Issuer will permit any of its Subsidiaries to, enter into any transaction of merger or consolidation, or liquidate, wind-up or dissolve itself (or suffer any liquidation
or dissolution), or convey, sell, lease or sublease (as lessor or sublessor), transfer or otherwise dispose of, in one transaction or a series of transactions, all or any part of its business, assets or property of any kind whatsoever, whether real,
personal or mixed and whether tangible or intangible, whether now owned or hereafter acquired, or acquire by purchase or otherwise (other than purchases or other acquisitions of inventory, materials and equipment in the ordinary course of business)
the business, property or fixed assets of or stock or other evidence of beneficial ownership of, any Person or any division or line of business or other business unit of any Person, or become a general partner in any partnership, except: 

(a) any Subsidiary of the Company may be merged or consolidated with or into the Issuers or any other Subsidiary of the
Company, or be liquidated, wound up or dissolved, or all or any part of its business, property or assets may be conveyed, sold, leased, transferred or otherwise disposed of, in one transaction or a series of transactions, to the Issuers or to a
Subsidiary Guarantor; provided that, in the case of any merger or consolidation involving a Wholly-Owned Subsidiary, the Person formed by such merger or consolidation shall be a Wholly-Owned Subsidiary of the Issuers; provided, further that, in the
case of any such merger or consolidation to which a Subsidiary Guarantor is a party, the Person formed by such merger or consolidation shall be a Guarantor; 
 (b) sales or other Dispositions of assets that do not constitute Asset Sales; 
 (c) Asset Sales, the proceeds of which (valued at the principal amount thereof in the case of non-cash proceeds consisting of notes or other debt Securities and valued at fair market value in the case of
other non-cash proceeds) (i) when aggregated with the proceeds of all other Asset Sales made within the same fiscal year, are less than $50,000,000 and (ii) when aggregated with the proceeds of all other Asset Sales made after the First
Amendment Effective Date and prior to the date of determination, are less than $100,000,000; provided (A) the consideration received for such assets shall be in an amount at least equal to the fair market value thereof (if the value is greater
than $5,000,000, as determined in good faith by the Board of Directors of the Company) and (B) no less than 90% of such consideration shall be paid in cash or in Capital Stock of the purchaser; 

  
 Exhibit A-5

 (d) disposals of obsolete, worn out or surplus property; 

(e) Permitted Acquisitions; 
 (f) Investments made in accordance with Section 10.16; 
 (g)
(i) Asset Sales by the Issuers or Subsidiary Guarantors to any of their Subsidiaries that are not Subsidiary Guarantors or to any Person in which the Issuers or one or more Wholly-Owned Subsidiaries of the Issuers own or will own upon consummation
of the Asset Sale 50% of the Capital Stock of such Person and (ii) Dispositions of no more than 50% of the Capital Stock of a Wholly-Owned Subsidiary that is not a Subsidiary Guarantor to any Person; provided the consideration received for such
assets or Dispositions in the case of the foregoing clauses (i) and (ii), as applicable, shall be in an amount at least equal to the fair market value thereof (if the value is greater than $5,000,000, as determined in good faith by the Board of
Directors of the Company); 
 (h) Asset Sales among the Issuers and the Subsidiary Guarantors; and 

(i) Asset Sales among Subsidiaries of the Issuers that are not Subsidiary Guarantors; 

provided, that, the Issuers will apply any Net Cash Proceeds (as defined in the Credit Agreement as in effect on the First Amendment
Effective Date) received in connection with any Asset Sale permitted under this Section 10.6 to prepay the loans under the Credit Agreement to the extent required by Section 2.11 of the Credit Agreement (as in effect on the First Amendment
Effective Date).” 
  

	 	14.	Section 10.7 of the Existing Note Purchase Agreement is hereby amended and restated in its entirety to read as follows: 

“10.7. Financial Covenants. 
 (a) Total Leverage Ratio. The Issuers will not permit the ratio of Consolidated Total Debt, as of the last day of any fiscal quarter of the Issuers, to Consolidated Adjusted EBITDA for the four
consecutive fiscal quarters ending on such last day to be greater than 2.0 to 1.0. With respect to any rolling four quarter period during which a Material Asset Sale, a Material Acquisition or, in the Company’s discretion, any other Permitted
Acquisition has occurred (each, a “Subject Transaction”), for purposes of determining compliance with foregoing covenant, Consolidated Adjusted EBITDA shall be calculated on a pro forma basis (without duplication) giving effect to
such Subject Transaction as if it had been consummated or incurred or repaid at the beginning of the relevant four quarter period. The determination of such pro forma Consolidated Adjusted EBITDA shall be further modified pursuant to
Section 10.7(c)(i). 
 (b) Fixed Charge Coverage Ratio. The Issuers will not permit the Fixed Charge
Coverage Ratio for any period of four consecutive fiscal quarters of the Issuers to be less than 1.25 to 1.00. 

  
 Exhibit A-6

 (c) Pro Forma Calculation. 

(i) For purposes of determining compliance with the financial covenants set forth in this Section 10.7, in the
determination of Consolidated Adjusted EBITDA the following items shall be added back to Consolidated Net Income for such period, to the extent deducted from revenues in the determination thereof and to the extent such items arise out of events
which are directly attributable to such Subject Transaction, are factually supportable and are reasonably expected to result in future cost savings or future revenue enhancement: severance costs, retention costs, consultant expenses, closure of
facilities, Legacy Costs and other similar restructuring and non-recurring charges incurred in connection with the Subject Transaction (such other restructuring and non-recurring charges not specifically listed in the preceding phrase to be subject
to the approval of the Required Holders); provided, however, that Legacy Costs attributable to a Subject Transaction shall not exceed $5,000,000 during the term of the Notes. 

(ii) With respect to any rolling four quarter period during which a Subject Transaction has occurred, for purposes of
determining compliance with the Fixed Charge Coverage Ratio, Consolidated Adjusted EBITDAR for such period shall be calculated, to the extent comprised of Consolidated Adjusted EBITDA, by computing Consolidated Adjusted EBITDA for such period in the
manner set forth in Section 10.7(c)(i). 
 (iii) The failure of the Company to include a Permitted
Acquisition in the calculations made pursuant to this Section 10.7 for any four quarter period including the quarter in which such Permitted Acquisition occurred shall not preclude the Company from including such Permitted Acquisition in the
calculations for any other four quarter period including the quarter in which such Permitted Acquisition occurred. 
 (iv) “Legacy Costs” means one-time expenses for the costs of lease or other contract terminations and other similar costs of the type described in Emerging Issues Task Force Issue 95-3,
“Recognition of Liabilities in connection with a Purchase Business Combination. 
 (v) The pro forma
adjustments calculated pursuant to Section 10.7 shall be set forth and certified by a Responsible Officer.” 
  

	 	15.	Section 10.8 of the Existing Note Purchase Agreement is hereby amended and restated in its entirety to read as follows: 

“10.8. Clauses Restricting Subsidiary Distributions. 

Except as provided herein, in any other Financing Document or pursuant to the organization documents of any Subsidiary
that is not a Wholly-Owned Subsidiary, neither Issuer will, and neither Issuer will permit any of its Subsidiaries to, create or otherwise cause or suffer to exist or become effective any consensual encumbrance or restriction of any kind on the
ability of any Subsidiary of the Company to: 

  
 Exhibit A-7

 (a) pay dividends or make any other distributions on any of such
Subsidiary’s Capital Stock owned by the Company or any other Subsidiary; or 
 (b) repay or prepay any
Indebtedness owed by such Subsidiary to the Company or any other Subsidiary.” 
  

	 	16.	Section 10.11 of the Existing Note Purchase Agreement is hereby amended and restated in its entirety to read as follows: 

“10.11. Restricted Payments. 
 Neither Issuer will, and neither Issuer will permit any of its Subsidiaries or Affiliates, through any manner or means or through any other Person to, directly or indirectly, declare, order, pay, make or
set apart, or agree to declare, order, pay, make or set apart, any sum for any Restricted Payment except that: 

(a) so long as no Default or Event of Default shall have occurred and be continuing (or would result therefrom on a pro
forma basis after giving effect to such payment), the Company may make Restricted Payments in an aggregate amount during the term of the Notes not to exceed the sum of (i) $30,000,000, (ii) at the time of such Restricted Payment, an amount
equal to (x) 50% of Consolidated Net Income for each fiscal quarter during the term of the Notes, to the extent positive, or minus (y) 100% of Consolidated Net Income for each fiscal quarter during the term hereof, to the extent negative,
plus (iii) if the ratio set forth in Section 10.7(a) is less than 1.0 to 1.0 for the fiscal quarter ended immediately prior to the incurrence of the one-time expenses and payments in respect thereof approved by the Required Holders as
described in the definition of Consolidated Adjusted EBITDA, such expenses and payments; and 
 (b) (i) any
Subsidiary may make Restricted Payments to its direct parent to the extent its parent is an Issuer or any of its Subsidiaries and (ii) any such Subsidiary that is not a Wholly-Owned Subsidiary may make distributions to Persons that are not
either an Issuer or a Subsidiary Guarantor, pro rata to such Persons’ ownership of such Subsidiary, and concurrently with the making of distributions to one or more of the Issuers and the Subsidiary Guarantors.” 

 

	 	17.	Section 10 of the Existing Note Purchase Agreement is hereby amended by adding the following new Sections 10.12, 10.13, 10.14, 10.15 and 10.16 at the end thereof
as follows: 

 “10.12. Indebtedness. 

Neither Issuer will, and neither Issuer will permit any of its Subsidiaries to, create, issue, incur, assume, become
liable in respect of or suffer or permit to exist any Indebtedness, except: 
 (a) Indebtedness of the Issuers
and Subsidiary Guarantors pursuant to any Financing Document; 

  
 Exhibit A-8

 (b) Indebtedness of the Issuers to each other or to any Subsidiary and of
any Subsidiary Guarantor to the Issuers or any other Subsidiary; 
 (c) Indebtedness of any Subsidiary that is
not a Subsidiary Guarantor to any other Subsidiary that is not a Subsidiary Guarantor; 
 (d) Guarantee
Obligations incurred in the ordinary course of business by the Issuers or any of their respective Subsidiaries of obligations of any Subsidiary Guarantor that is a Wholly-Owned Subsidiary; 

(e) Indebtedness outstanding on the First Amendment Effective Date and listed on Schedule 10.12, but not any extensions,
renewals or replacements of such Indebtedness except (i) renewals and extensions expressly provided for in the agreements evidencing any such Indebtedness as the same are in effect on the First Amendment Effective Date, or
(ii) refinancings and extensions of any such Indebtedness if the terms and conditions thereof are not more favorable to the lenders than the terms and conditions provided by the lenders of the existing Indebtedness, and the average life to
maturity thereof is greater than or equal to that of the Indebtedness being refinanced or extended; provided, such Indebtedness permitted under the immediately preceding clause (i) or (ii) above shall not (A) include Indebtedness of
an obligor that was not an obligor with respect to the Indebtedness being extended, renewed or refinanced, (B) exceed in a principal amount the Indebtedness being renewed, extended or refinanced or (C) be incurred, created or assumed if
any Default or Event of Default has occurred and is continuing or would result therefrom; and any refinancings, refundings, renewals or extensions thereof (without increasing, or shortening the maturity of, the principal amount thereof); 

(f) Indebtedness (including, without limitation, obligations in respect of Capital Leases) secured by Liens permitted by
Section 10.5(h) in an aggregate principal amount not to exceed $10,000,000 at any one time outstanding; 

(g) (i) Indebtedness of the Issuers incurred under the Credit Agreement in an aggregate principal amount not to exceed
$325,000,000; and 
 (ii) Guarantee Obligations of any Subsidiary Guarantor in respect of such Indebtedness, but
not any extensions, renewals or replacements of such Indebtedness except refinancings and extensions of any such Indebtedness if the terms and conditions thereof are not more favorable to the lenders than the terms and conditions provided by the
lenders of the existing Indebtedness, and the average life to maturity thereof is greater than or equal to that of the Indebtedness being refinanced or extended; 

(h) additional Indebtedness of the Issuers or any of their Subsidiaries in an unsecured aggregate principal amount (for
the Issuers and all Subsidiaries) not to exceed $50,000,000 at any one time outstanding, excluding Indebtedness permitted by clause (o) below; 

  
 Exhibit A-9

 (i) (i) Indebtedness of a Person that becomes a Subsidiary or Indebtedness
incurred to finance assets of a Person that are acquired by the Issuers or any of their Subsidiaries, in either case, as the result of a Permitted Acquisition in an aggregate amount not to exceed at any time $20,000,000; provided that (x) such
Indebtedness existed at the time such Person became a Subsidiary or at the time such assets were acquired by the Issuers or any of their Subsidiaries and, in each case, was not created in anticipation thereof and (y) such Indebtedness is not
guaranteed in any respect by the Issuers or any of their Subsidiaries (other than by any such Person that so becomes a Subsidiary), and (ii) any refinancing, refunding, renewal or extension of any Indebtedness specified in Section 10.12(f)
or subclause (i) of this Section 10.12(i); provided, that (1) the principal amount of any such Indebtedness is not increased above the principal amount thereof outstanding immediately prior to such refinancing, refunding, renewal or
extension, (2) the direct and contingent obligors with respect to such Indebtedness are not changed and (3) such Indebtedness shall not be secured by any assets other than the assets securing the Indebtedness being renewed, extended or
refinanced; 
 (j) Indebtedness in respect of netting services, overdraft protections and otherwise in connection
with deposit accounts; 
 (k) Indebtedness in respect of earnouts in connection with Permitted Acquisitions;

 (l) Indebtedness in respect of Specified Swap Agreements; 

(m) other secured Indebtedness of the Issuers or any of their Subsidiaries in an aggregate amount not to exceed at any
time $10,000,000 in addition to Indebtedness described in Schedule 10.12; 
 (n) Indebtedness in respect of the
Company’s non-qualified deferred compensation plan (as defined in § 409A(d)(1) of the Code and related regulations thereunder) to the extent the assets of such plan are reflected on the consolidated balance sheet of the Company and its
Subsidiaries; 
 (o) Indebtedness of all Subsidiaries that are not Subsidiary Guarantors to the Issuers or
Subsidiary Guarantors in an aggregate amount not to exceed at any time $40,000,000 for all such Subsidiaries; and 
 (p) other unsecured Indebtedness of the Issuers or any of their Subsidiaries owed to sellers in connection with Permitted Acquisitions in an aggregate principal amount not to exceed at any time the sum of
$75,000,000 minus any of such Indebtedness described in Schedule 10.12; provided that no such Indebtedness shall require the Issuers or any of their Subsidiaries to comply with any financial covenants. 

  
 Exhibit A-10

 10.13. Most Favored Lender. 

(a) If at any time the Credit Agreement contains a Financial Covenant that is not contained in this Agreement or which
would in any respect be more beneficial to the holders of Notes than the Financial Covenants set forth in this Agreement (any such provision, a “More Favorable Covenant”), then the Issuers shall provide a Most Favored Lender Notice
in respect of such More Favorable Covenant. Thereupon, unless waived in writing by the Required Holders within 15 Business Days after each holder’s receipt of such notice, such More Favorable Covenant shall be deemed automatically incorporated
by reference into this Section 10.13, mutatis mutandis, as if set forth in full herein, effective as of the date when such More Favorable Covenant shall have become effective under the Credit Agreement. Thereafter, upon the written
request of any holder of a Note, the Issuers shall enter into any additional agreement or amendment to this Agreement reasonably requested by such holder evidencing any of the foregoing. 

(b) Any More Favorable Covenant incorporated into this Agreement (herein referred to as an “Incorporated
Covenant”) shall remain unchanged herein notwithstanding any subsequent waiver, amendment or other modification of such More Favorable Covenant under the Credit Agreement, provided that, for the avoidance of doubt, if such More Favorable
Covenant contains by its terms a sunset provision, an automatic “step-down”, or any other provision which makes such More Favorable Covenant under the Credit Agreement less restrictive on the Company, then such sunset provision, automatic
“step-down”, or other provision shall apply to the Incorporated Covenant herein so long as the Financial Covenant that is the subject of such Incorporated Covenant is not made less restrictive than such Financial Covenant in this Agreement
as in effect on the First Amendment Effective Date. 
 (c) For the avoidance of doubt and notwithstanding
anything to the contrary herein, each of the covenants included in this Agreement as of the First Amendment Effective Date and any other covenant that is not an Incorporated Covenant shall not be made less restrictive on the Company and shall remain
in this Agreement (unless amended or deleted in accordance with Section 17) regardless of whether any Incorporated Covenants are incorporated into this Agreement or deleted herefrom. 

(d) “Financial Covenant” means any covenant (whether set forth as a covenant, event of default, or other
such substantially similar provision having the same effect) that requires the Company to achieve or maintain a stated level of financial condition or performance and includes, without limitation, any requirement that the Company: 

(i) maintain a specified level of net worth, total assets, cash flow or net income; 

(ii) maintain any ratio or level of any component of its capital structure to (or in comparison to) any other component
of its capital structure including, without limitation, any requirement that the Company maintain any specified ratio or level of Indebtedness, senior or secured Indebtedness, subordinated Indebtedness or any other measure of Indebtedness of the
Company and its Subsidiaries, individually or on a consolidated basis, to Consolidated Adjusted EBITDA, cash flow or any other component (whether or not adjusted) of the Company’s or its Subsidiaries’ consolidated or individual capital
structure, balance sheet, income statement or results of operations; or 

  
 Exhibit A-11

 (iii) maintain any measure of its ability to service its Indebtedness
(including, without limitation, exceeding any specified ratio of revenues, cash flow or net income to interest expense, rental expense, capital expenditures and/or scheduled payments of Indebtedness). 

Any covenant similar to the covenants set forth in Section 10.7 shall be deemed to be a Financial Covenant.

 (e) “Most Favored Lender Notice” means, in respect of any More Favorable Covenant, a written
notice to each of the holders of the Notes delivered promptly, and in any event with 15 Business Days after the inclusion of such More Favorable Covenant in the Credit Agreement (including by way of amendment or other modification of any existing
provision thereof), from a Senior Financial Officer of the Company referring to the provisions of this Section 10.13 and setting forth a reasonably detailed description of such More Favorable Covenant (including any defined terms used therein)
and related explanatory calculations, as applicable. 
 10.14. No Foreign Subsidiaries or Certain Other Subsidiaries.

 Neither Issuer shall, nor shall it permit any of its Subsidiaries to, create, acquire or otherwise own
directly or indirectly: 
 (a) any Foreign Subsidiary; 

(b) prior to such time as the Company complies with Section 9.9 and except with respect to the Specified Entities and
Immaterial Subsidiaries, any Subsidiary that is not a Wholly-Owned Subsidiary with respect to which the Issuers have not used commercially reasonable efforts to obtain consents to the following actions from all of the owners of Capital Stock
therein: (i) to pledge the Capital Stock of such Subsidiary owned by the Issuers or any of their Subsidiaries to secure the Notes and (ii) to admit the collateral agent for the holders of Notes or its designee as a substitute member or
partner, as the case may be, following any foreclosure on such Capital Stock; and 
 (c) from and after such time
as the Company complies with Section 9.9 and except with respect to the Specified Entities and Immaterial Subsidiaries, any Subsidiary that is not a Wholly-Owned Subsidiary with respect to which consents to the actions described in clause
(b) above have not been obtained from all of the owners of Capital Stock therein. 
 10.15 Specified Entities.
 
 The Issuers shall not permit the aggregate Net Revenues of the Specified Entities to exceed 5% of the consolidated Net
Revenues of the Company and its Subsidiaries (excluding any contribution to Net Revenues from Subsidiaries that are not Wholly-Owned Subsidiaries). 

  
 Exhibit A-12

 10.16 Investments. 

Neither Issuer will, and neither Issuer will permit any of its Subsidiaries to, directly or indirectly, make or own any
Investment in any Person, except: 
 (a) Cash Equivalents; 

(b) (i) equity Investments owned as of the First Amendment Effective Date in any Wholly-Owned Subsidiary of the Issuers,
and (ii) Investments made after the First Amendment Effective Date in Wholly-Owned Subsidiaries that are Subsidiary Guarantors; 
 (c) (i) Investments in any Securities received in satisfaction or partial satisfaction thereof from financially troubled account debtors and (ii) deposits, prepayments and other credits to suppliers
made in the ordinary course of business consistent with the past practices of the Issuers or any of their Subsidiaries; 
 (d) intercompany Indebtedness to the extent permitted under clauses (b), (c) and (o) of Section 10.12; 

(e) Guarantee Obligations to the extent permitted under Section 10.12(d); 

(f) Consolidated Capital Expenditures; 

(g) Investments in assets useful in the business of the Issuers and their Subsidiaries made by the Issuers or any of their
Subsidiaries with the proceeds of any Reinvestment Deferred Amount (as defined in the Credit Agreement as in effect on the First Amendment Effective Date); 
 (h) loans and advances to employees of the Issuers or any of their Subsidiaries made in the ordinary course of business in compliance with applicable Requirements of Law (including Section 402 of the
Sarbanes-Oxley Act) in an aggregate principal amount not to exceed at any time $1,000,000; 
 (i) Investments
made in connection with Permitted Acquisitions and Asset Sales, in each case, permitted pursuant to Section 10.6; and 
 (j) (i) equity Investments owned as of the First Amendment Effective Date in Persons that are not Wholly-Owned Subsidiaries of the Issuers and described on Schedule 10.16, and (ii) other Investments
not permitted by any other clause of this Section 10.16 made after the First Amendment Effective Date in Persons that are not Wholly-Owned Subsidiaries that are Subsidiary Guarantors in an aggregate amount under this clause (ii) not to
exceed at any time $80,000,000.” 

  
 Exhibit A-13

	 	18.	Sections 11(c) and 11(d) of the Existing Note Purchase Agreement are hereby amended and restated in their entirety to read as follows: 

“(c) either Issuer defaults in the performance of or compliance with any term contained in Section 7.1(d), Section 9.5,
Section 9.8(b), Section 10.3, Section 10.6, Section 10.7, Section 10.8, Section 10.9, Section 10.11, Sections 10.13 to 10.16, inclusive, or any Incorporated Covenant (after giving effect to the grace period (if
applicable) in respect of such comparable covenant in the Credit Agreement, without duplication of any grace period contained herein); 
 (d) either Issuer defaults in the performance of or compliance with any term contained herein (other than those referred to in Sections 11(a), (b) and (c)) and such default is not remedied within 10
Business Days after the earlier of (i) a Responsible Officer obtaining actual knowledge of such default and (ii) either Issuer receiving written notice of such default from any holder of a Note (any such written notice to be identified as
a “notice of default” and to refer specifically to this Section 11(d));” 
  

	 	19.	Section 11 of the Existing Note Purchase Agreement is hereby amended by replacing the period at the end of clause (k) thereof with “; or” and
inserting the following new clause (l) read as follows: 

 “(l) any Lien created by the Security and
Pledge Agreement shall at any time fail to constitute a valid and (to the extent required by the Security and Pledge Agreement or as otherwise permitted under this Agreement) perfected Lien on any material portion of the collateral purported to be
subject thereto, securing the obligations purported to be secured thereby, with the priority required by the Financing Documents, or any of the Issuers or Subsidiary Guarantors shall so assert in writing, in each case other than as a result of
action or inaction of any holder of Notes.” 
  

	 	20.	Section 22.3 of the Existing Note Purchase Agreement is hereby amended and restated in its entirety to read as follows: 

“22.3. Accounting Terms. 
 All accounting terms used herein which are not expressly defined in this Agreement have the meanings respectively given to them in accordance with GAAP. Except as otherwise specifically provided herein,
(a) all computations made pursuant to this Agreement shall be made in accordance with GAAP, and (b) all financial statements shall be prepared in accordance with GAAP; provided that, if the Issuers notify the holders of Notes that the
Issuers request an amendment to any provision hereof to eliminate the effect of any change occurring after the First Amendment Effective Date in GAAP or in the application thereof on the operation of such provision (or if the Required Holders notify
the Issuers that the Required Holders request an amendment to any provision hereof for such purpose), regardless of whether any such notice is given before or after such change in GAAP or in the application thereof, then such provision shall be
interpreted on the basis of GAAP as in effect and applied immediately before such change shall have become effective until such notice shall have been withdrawn or such provision amended in accordance herewith. For purpose of determining compliance
with any provision of this Agreement, the determination of whether a lease is to be treated as an operating lease or capital lease shall be made without giving effect to any change in accounting for

  
 Exhibit A-14

 
leases pursuant to GAAP resulting from the implementation of proposed Accounting Standards Update (ASU) Leases (Topic 840) issued August 17, 2010, or any successor proposal. Notwithstanding
any other provision contained herein, all terms of an accounting or financial nature used herein shall be construed, and all computations of amounts and ratios referred to herein shall be made, (x) without giving effect to any election under
Accounting Standards Codification 825-10-25 (or any other Financial Accounting Standard having a similar result or effect) to value any Indebtedness or other liabilities of the Issuers or any Subsidiary at “fair value”, as defined therein
and (y) without giving effect to any treatment of Indebtedness in respect of convertible debt instruments under Accounting Standards Codification 470-20 (or any other Accounting Standards Codification or Financial Accounting Standard having a
similar result or effect) to value any such Indebtedness in a reduced or bifurcated manner, as described therein, and such Indebtedness shall at all times be valued at the full stated principal amount thereof.” 

 

	 	21.	Section 22 of the Existing Note Purchase Agreement is hereby amended by adding the following new Section 22.9 at the end thereof as follows:

 “22.9 Releases of Guarantees and Liens. 

(a) Notwithstanding anything to the contrary contained herein or in any other Financing Document, the holders of Notes
agree to take any action requested by the Issuers, at their expense, having the effect of releasing any Guarantee Obligations in respect of the Notes and the pledge of any Capital Stock under Section 9.9 (i) to the extent necessary to
permit consummation of any transaction not prohibited by any Financing Document or that has been consented to in accordance with Section 17 or (ii) under the circumstances described in paragraph (b) below. 

(b) At such time as (i) any Subsidiary Guarantor is released from its guaranty or other obligations under the Credit
Agreement or (ii) the Notes and the other obligations under the Financing Documents shall have been paid in full, then the holders of Notes shall, upon written request from the Issuers and at their expense, release the Issuers and Subsidiary
Guarantors from their respective obligations under the Subsidiary Guaranty and/or the Security and Pledge Agreement, as applicable, pursuant to documents reasonably satisfactory to the Required Holders, so long as, in the case of a release under
clause (i): 
 (i) no Default or Event of Default exists or would exist immediately after such release,

 (ii) no claim has been made against such Subsidiary Guarantor under the Subsidiary Guaranty, and 

(ii) if the lenders under the Credit Agreement (or any of their Affiliates) have been or will be paid a fee or given any
other remuneration in connection with the release of such Subsidiary Guarantor from such guaranty, security document or other obligations, each holder of Notes has received, or will receive, 

  
 Exhibit A-15

 
as the case may be, such fee or other remuneration at the same time it has been or will be paid to such lenders and in an amount, per dollar of outstanding principal, that is equal to what is or
will be paid to such lenders per dollar of credit at risk under the Credit Agreement (for the avoidance of doubt, “credit at risk” to be understood to mean the sum of outstanding principal plus the aggregate face amount of outstanding
letters of credit plus, if no default or event of default under the Credit Agreement is then continuing, the aggregate undrawn amount of the Commitments, as such term is defined in the Credit Agreement).” 

 

	 	22.	Schedule B of the Existing Note Purchase Agreement is hereby amended by amending and restating the following terms: 

“‘Capital Stock’ means any and all shares, interests, participations or other equivalents (however designated) of
capital stock of a corporation, any and all equivalent ownership interests in a Person (other than a corporation), including, without limitation, partnership interests and membership interests, and any and all warrants, rights or options to purchase
or other arrangements or rights to acquire any of the foregoing.” 
 “‘Company’ means Amedisys, Inc.,
a Delaware corporation.” 
 “‘Consolidated Adjusted EBITDA’ means, for any period, an amount
determined on a consolidated basis for the Company and its Subsidiaries equal to (i) the sum, without duplication, of the amounts for such period of (a) Consolidated Net Income, plus (b), to the extent deducted from revenues in the
determination of such Consolidated Net Income, Consolidated Interest Expense, provisions for Taxes based on income, total depreciation expense, total amortization expense, and other non-cash items reducing Consolidated Net Income (excluding any such
non-cash item to the extent that it represents an accrual or reserve for potential cash items in any future period or amortization of a prepaid cash item that was paid in a prior period) minus (ii) other non-cash items increasing Consolidated
Net Income for such period (excluding (A) any such non-cash item to the extent it represents the reversal of an accrual or reserve for potential cash items to the extent that such accrual or reserve was created in such period and (B) any
such non-cash item to the extent it will result in the receipt of cash payments in any future period or in respect of which cash was received in a prior period). Consolidated Adjusted EBITDA shall be adjusted to add back to Consolidated Net Income,
to the extent deducted therefrom, any one-time expenses and any payments in respect thereof that are approved by the Required Holders.” 
 “‘Consolidated Net Income” means, for any period, (i) the net income (or loss) of the Company and its Subsidiaries for such period taken as a single accounting period determined
on a consolidated basis in conformity with GAAP, minus (ii) (a) the income (or loss) of any Person accrued prior to the date it becomes a Subsidiary of the Company or its merged into or consolidated with the Company or any of its
Subsidiaries or that Person’s assets are acquired by the Company or any of its Subsidiaries, (b) the income of any Subsidiary of the Company to the extent that the declaration or payment of dividends or similar distributions by that
Subsidiary of that income is not at the time permitted by operation of the terms of its charter or any agreement, instrument, 

  
 Exhibit A-16

 
judgment, decree, order, statute, rule or governmental regulation applicable to that Subsidiary, (c) any after-tax gains or losses attributable to a Material Asset Sale or returned surplus
assets of any pension plan, (d) the income of any Subsidiary that is not a Wholly-Owned Subsidiary except to the extent such income is distributed in cash to an Issuer or a Subsidiary Guarantor, and (e) (to the extent not included in
clauses (a) through (c) above) any net extraordinary non-cash gains or net extraordinary non-cash losses.” 

“‘Credit Agreement’ means the Credit Agreement, dated as of October 26, 2012, among the Issuers, JPMorgan Chase
Bank, N.A., as administrative agent, and certain other agents and lenders party thereto, and any refinancing or replacement thereof.” 
 “‘Disposition” means, with respect to any property, any sale, lease, sale and leaseback, assignment, conveyance, transfer or other disposition thereof. The terms
“Dispose” and “Disposed of” shall have correlative meanings.” 
 “‘Financing
Documents” means this Agreement, the Notes, the Subsidiary Guaranty and the Security and Pledge Agreement.” 

“‘Fixed Charge Coverage Ratio” means, for any period of four fiscal quarters of the Issuers, the ratio of
(i) Consolidated Adjusted EBITDAR minus Consolidated Capital Expenditures minus Taxes based on income that are paid in cash, in each case for such period, to (ii) scheduled payments of principal on Indebtedness of the Company and its
Subsidiaries (other than such payments in respect of the Notes) plus Consolidated Cash Interest Expense plus Consolidated Rent, in each case, for such period. 
 “‘GAAP’ means generally accepted accounting principles in the United States as in effect from time to time, except that for purposes of Section 10.7, GAAP shall be determined on
the basis of such principles in effect on the First Amendment Effective Date and consistent with those used in the preparation of the audited financial statements for the period ending December 31, 2011 required to be delivered pursuant to
Section 7.1.” 
 “‘Holding’ means Amedisys Holding, L.L.C., a Louisiana limited liability
company.” 
 “‘Investments’ means (a) any direct or indirect purchase or other acquisition by the
Issuers, or any of their Subsidiaries of, or of a beneficial interest in, any of the Securities of any other Person (other than a Subsidiary Guarantor); (b) any direct or indirect redemption, retirement, purchase or other acquisition for value,
by any Subsidiary of the Issuers from any Person (other than the Issuers or any Subsidiary Guarantor), of any Capital Stock of such Person; and (c) any direct or indirect loan, advance (other than advances to employees for moving, entertainment
and travel expenses, drawing accounts and similar expenditures in the ordinary course of business) or capital contribution by the Issuers or any of their Subsidiaries to any other Person (other than the Issuers or any Subsidiary Guarantor),
including all Indebtedness and accounts receivable from that other Person that are not current assets or did not arise from sales to that other Person in the ordinary course of business. The amount of any Investment shall be the original cost of
such Investment plus the cost of all additions thereto, without any adjustments for increases or decreases in value, or write-ups, write-downs or write-offs with respect to such Investment.” 

  
 Exhibit A-17

 “‘Material Adverse Effect’ means any event, development or
circumstance that has had or would reasonably be expected to have a material adverse effect on (a) the business, operations, condition (financial or otherwise) or prospects of the Issuers and their Subsidiaries taken as a whole, or (b) the
ability of the Issuers and the Subsidiary Guarantors to perform their obligations under any Financing Document, (c) the legality, validity, binding effect or enforceability of any of the Financing Documents against the Issuers and Subsidiary
Guarantors or the rights and remedies of the holders of Notes thereunder or (d) the rights, remedies and benefits available to, or conferred upon, the holders of Notes hereunder and under any Financing Document.” 

“‘Material Asset Sale’ means any Asset Sale, other than in connection with a Permitted Acquisition, involving the
disposition of property that (a) constitutes assets comprising all or substantially all of an operating unit of a business or constitutes all or substantially all of the Capital Stock of a Person and (b) yields gross proceeds to the
Issuers and their Subsidiaries in excess of $5,000,000.” 
 “‘Permitted Acquisition’ means any
acquisition by the Issuers or any of their Wholly-Owned Subsidiaries, whether by purchase, merger or otherwise, of all or substantially all of the assets of, or of 50% or more of the Capital Stock of, or a business line or unit or a division of, any
Person; provided, (a) immediately prior to, and after giving pro forma effect thereto, no Event of Default or Default shall have occurred and be continuing or would result therefrom; (b) the Issuers and their Subsidiaries shall have
delivered to the holders of the Notes at least five Business Days prior to such proposed acquisition, a certificate evidencing on a pro forma basis after giving effect to such acquisition that the ratio set forth in Section 10.7(a) is less than
or equal to 1.75 to 1.00, (c) such acquisition and all transactions related thereto (i) shall be consummated in accordance with all material applicable laws and (ii) shall not be preceded by, or effected pursuant to, a hostile
takeover offer and (d) that after giving effect thereto, none of the Issuers, the Subsidiary Guarantors or their Subsidiaries shall engage in any business other than (i) the businesses engaged or proposed to be engaged in (provided such
proposal is in writing and disclosed to the holders of Notes) by the Issuers, the Subsidiary Guarantors and their Subsidiaries, taken as a whole, on the First Amendment Effective Date and similar or related businesses and (ii) such other lines
of business as may be consented to by Required Holders.” 
 “‘Specified Swap Agreement’ means any Swap
Agreement in respect of interest rates, currency exchange rates or commodity prices, in each case, entered into for hedging purposes by the Issuers or any Subsidiary Guarantor and any Person that is a lender under the Credit Agreement or an
Affiliate of any such lender at the time such Swap Agreement is entered into.” 
 “‘Subject
Transaction’ is defined in Section 10.7(a).” 

  
 Exhibit A-18

 “‘Subsidiary’ means, as to any Person (the “parent”) at any
date, any corporation, partnership, limited liability company or other entity the accounts of which would be consolidated with those of the parent in the parent’s consolidated financial statements if such financial statements were prepared in
accordance with GAAP as of such date, as well as any other corporation, partnership, limited liability company or other entity of which securities or other ownership interests representing more than 50% of the equity or more than 50% of the ordinary
voting power or, in the case of a partnership, more than 50% of the general partnership interests are, are of such date, owned, controlled or held (whether directly or indirectly) by the parent or the parent’s other Subsidiaries. Unless the
context otherwise clearly requires, any reference to a “Subsidiary” is a reference to a Subsidiary of the Company.” 
 “‘Subsidiary Guarantors’ means each Original Subsidiary Guarantor and each Subsidiary required to execute a Guaranty Joinder Agreement pursuant to Section 9.8.” 

 

	 	23.	Schedule B of the Existing Note Purchase Agreement is hereby amended by adding the following new terms in proper alphabetical order: 

“‘Asset Sale’ means any sale, lease or sub-lease (as lessor or sublessor), sale and leaseback, assignment,
conveyance, exclusive license (as licensor or sublicensor), transfer or other Disposition to, or any exchange of property with, any Person (other than the Issuers or any Subsidiary Guarantor), in one transaction or a series of transactions, of all
or any part of the Issuers’ or any of their Subsidiaries’ businesses, assets or properties of any kind, whether real, personal, or mixed and whether tangible or intangible, whether now owned or hereafter acquired, leased or licensed,
including, without limitation, the Capital Stock of any of the Issuers’ Subsidiaries, other than inventory sold or leased in the ordinary course of business (excluding any such sales, leases or licenses by operations or divisions discontinued
or to be discontinued).” 
 “‘Cash Equivalents’ means (a) marketable direct obligations issued
by, or unconditionally guaranteed by, the United States Government or issued by any agency thereof and backed by the full faith and credit of the United States, in each case maturing within one year from the date of acquisition;
(b) certificates of deposit, time deposits, Eurodollar time deposits or overnight bank deposits having maturities of six months or less from the date of acquisition issued by any lender under the Credit Agreement or by any commercial bank
organized under the laws of the United States or any state thereof having combined capital and surplus of not less than $500,000,000; (c) commercial paper of an issuer rated at least A-1 by S&P or P-1 by Moody’s, or carrying an
equivalent rating by a nationally recognized rating agency, if both of the two named rating agencies cease publishing ratings of commercial paper issuers generally, and maturing within six months from the date of acquisition; (d) repurchase
obligations of any lender under the Credit Agreement or of any commercial bank satisfying the requirements of clause (b) of this definition, having a term of not more than 30 days, with respect to Securities issued or fully guaranteed or
insured by the United States government; (e) Securities with maturities of one year or less from the date of acquisition issued or fully guaranteed by any state, commonwealth or territory of the United States, by any political subdivision or
taxing authority of any such state, commonwealth or territory or by any foreign government, the Securities of which state, commonwealth, territory, political subdivision, taxing authority or foreign government (as the case may be) are rated at least
A-1 by S&P or P-1 by 

  
 Exhibit A-19

 
Moody’s; (f) Securities with maturities of six months or less from the date of acquisition backed by standby letters of credit issued by any lender under the Credit Agreement or any
commercial bank satisfying the requirements of clause (b) of this definition; (g) money market mutual or similar funds that invest exclusively in assets satisfying the requirements of clauses (a) through (f) of this definition;
or (h) money market funds that (i) comply with the criteria set forth in SEC Rule 2a-7 under the Investment Company Act of 1940, as amended, (ii) are rated AAA by S&P and Aaa by Moody’s and (iii) have portfolio assets of
at least $1,000,000,000.” 
 “‘Financial Covenant’ is defined in Section 10.13(d).”

 “‘First Amendment Effective Date” means October 26, 2012.” 

“‘Foreign Subsidiary’ means any Subsidiary of the Company that is not a U.S. Person.” 

“‘Guarantee Obligation’ means as to any Person (the “guaranteeing person”), any obligation,
including a reimbursement, counterindemnity or similar obligation, of the guaranteeing person that guarantees or in effect guarantees, or which is given to induce the creation of a separate obligation by another Person (including any bank under any
letter of credit) that guarantees or in effect guarantees, any Indebtedness, leases, dividends or other obligations (the “primary obligations”) of any other third Person (the “primary obligor”) in any manner,
whether directly or indirectly, including any obligation of the guaranteeing person, whether or not contingent, (i) to purchase any such primary obligation or any property constituting direct or indirect security therefor, (ii) to advance
or supply funds (1) for the purchase or payment of any such primary obligation or (2) to maintain working capital or equity capital of the primary obligor or otherwise to maintain the net worth or solvency of the primary obligor,
(iii) to purchase property, Securities or services primarily for the purpose of assuring the owner of any such primary obligation of the ability of the primary obligor to make payment of such primary obligation or (iv) otherwise to assure
or hold harmless the owner of any such primary obligation against loss in respect thereof; provided, however, that the term Guarantee Obligation shall not include endorsements of instruments for deposit or collection in the ordinary course of
business. The amount of any Guarantee Obligation of any guaranteeing person shall be deemed to be the lower of (a) an amount equal to the stated or determinable amount of the primary obligation in respect of which such Guarantee Obligation is
made and (b) the maximum amount for which such guaranteeing person may be liable pursuant to the terms of the instrument embodying such Guarantee Obligation, unless such primary obligation and the maximum amount for which such guaranteeing
person may be liable are not stated or determinable, in which case the amount of such Guarantee Obligation shall be such guaranteeing person’s maximum reasonably anticipated liability in respect thereof as determined by the Company in good
faith.” 
 “‘Immaterial Subsidiary” means one or more Subsidiaries that are not Wholly-Owned
Subsidiaries and to which 3% or less of Consolidated Adjusted EBITDA in the aggregate is attributable.” 

“‘Incorporated Covenant’ is defined in Section 10.13(b).” 

“‘Moody’s’ means Moody’s Investors Services, Inc.” 

“‘More Favorable Covenant’ is defined in Section 10.13(a).” 

  
 Exhibit A-20

 “‘Most Favored Lender Notice’ is defined in
Section 10.13(e).” 
 “‘Net Revenues’ means, for any Person, the gross revenues of such Person,
net of estimated revenue and contractual adjustments in accordance with such Person’s revenue recognition policies and in accordance with GAAP.” 
 “‘Requirement of Law’ means as to any Person, the certificate of incorporation and bylaws or other organizational or governing documents of such Person, and any law, treaty, rule or
regulation or determination of an arbitrator or a court or other Governmental Authority, in each case applicable to or binding upon such Person or any of its property or to which such Person or any of its property is subject.” 

“‘Security and Pledge Agreement’ means a security and pledge agreement executed by the Company and certain of its
Wholly-Owned Subsidiaries in favor of the holders of Notes pursuant to Section 9.9, in form and substance satisfactory to the Required Holders.” 
 “‘U.S. Person’ means a “United States person” within the meaning of Section 7701(a)(30) of the Code.” 

“‘S&P’ means Standard & Poor’s Ratings Group, a division of The McGraw Hill Corporation.”

 “‘Specified Entities” means, collectively, Heart of the Rockies Home Health, LLC, Wentworth Home Care
and Hospice, LLC, Marietta Home Health and Hospice, LLC, Tri Cities Home Health, LLC, Amedisys Valley Texas, L.L.C., Portneuf Home Health Care, LLC and Saint Alphonsus Home Health and Hospice, LLC.” 

 

	 	24.	Schedule B of the Existing Note Purchase Agreement is hereby amended by deleting the following terms: 

“Additional Significant Subsidiary” 
 “Applicable Prepayment Date” 
 “Applicable Prepayment
Offer” 
 “Capital Stock Issuance” 

“Consolidated Total Tangible Assets” 
 “Debt Prepayment Application” 
 “Debt Prepayment
Transfer” 
 “Disposition Value” 

“Interest Rate Increase Period” 
 “Ratable Portion” 

  
 Exhibit A-21

 “Restructuring Charges” 

“Transfer” 
  

	 	25.	The Existing Note Purchase Agreement is hereby amended by adding Schedule 10.12 attached to this Amendment as Schedule 10.12 to the Existing Note Purchase Agreement.

  

	 	26.	The Existing Note Purchase Agreement is hereby amended by adding Schedule 10.16 attached to this Amendment as Schedule 10.16 to the Existing Note Purchase Agreement.

  

	 	27.	The Existing Note Purchase Agreement is hereby amended by deleting Exhibit 1 thereto and inserting Exhibit B attached hereto as Exhibit 1 in lieu thereof.

  

	 	28.	The Existing Note Purchase Agreement is hereby amended by deleting Exhibit 2 thereto and inserting Exhibit C attached hereto as Exhibit 2 in lieu thereof.

  
 Exhibit A-22

 EXHIBIT B 
 EXHIBIT 1 
 [FORM OF
SERIES A NOTE] 
 AMEDISYS, INC. 

AMEDISYS HOLDING, L.L.C. 
 6.07% SERIES A SENIOR NOTE DUE MARCH 25, 2013 

 

			
	No. RA-[    ]	  	[Date]
	$[            ]	  	PPN: 02343@ AA8

 FOR VALUE RECEIVED, the undersigned, AMEDISYS, INC., a corporation organized and existing under
the laws of the State of Delaware and AMEDISYS HOLDING, L.L.C., a limited liability company organized and existing under the laws of the State of Louisiana (collectively, the “Issuers”) hereby promise to pay to
[                        ], or registered assigns, the principal sum of
[                                ] Dollars (or so much thereof as shall not have been
prepaid) on March 25, 2013, with interest (computed on the basis of a 360-day year of twelve 30-day months) (a) on the unpaid balance hereof at the rate of 6.07% per annum, from the date hereof, payable semiannually, on the 25th day
of March and September in each year, commencing with the March 25th or September 25th next succeeding the date hereof, until the principal hereof shall have become due and payable, and (b) to the extent permitted by law, on any
overdue payment of interest and, during the continuance of an Event of Default, on such unpaid balance and on any overdue payment of any Make-Whole Amount, at a rate per annum from time to time equal to the greater of (i) 2% per annum above the
rate otherwise in effect with respect to this Note or (ii) 2% over the rate of interest publicly announced by JPMorgan Chase Bank, N.A. from time to time in New York, New York as its “base” or “prime” rate, payable
semiannually as aforesaid (or, at the option of the registered holder hereof, on demand). 
 Payments of principal of, interest
on and any Make-Whole Amount with respect to this Note are to be made in lawful money of the United States of America at the principal office of JPMorgan Chase Bank, N.A. in New York, New York or at such other place as the Issuers shall have
designated by written notice to the holder of this Note as provided in the Note Purchase Agreement referred to below. 
 This
Note is one of a series of 6.07% Series A Senior Notes (herein called the “Notes”), aggregating $35,000,000 in original aggregate principal amount, issued pursuant to the Note Purchase Agreement, dated as of March 25, 2008 (as
from time to time amended, the “Note Purchase Agreement”), among the Issuers and the respective Purchasers named therein and is entitled to the benefits thereof. Each holder of this Note will be deemed, by its acceptance hereof, to
have (i) agreed to the confidentiality provisions set forth in Section 20 of the Note Purchase Agreement and (ii) made the representation set forth in Section 6.2 of the Note Purchase Agreement. Unless otherwise indicated,
capitalized terms used in this Note shall have the respective meanings ascribed to such terms in the Note Purchase Agreement. 

  
 Exhibit B-1

 This Note is a registered Note and, as provided in the Note Purchase Agreement, upon
surrender of this Note for registration of transfer accompanied by a written instrument of transfer duly executed, by the registered holder hereof or such holder’s attorney duly authorized in writing, a new Note for a like principal amount will
be issued to, and registered in the name of, the transferee. Prior to due presentment for registration of transfer, the Issuers may treat the person in whose name this Note is registered as the owner hereof for the purpose of receiving payment of
principal, interest and any Make-Whole Amount and for all other purposes, and the Issuers will not be affected by any notice to the contrary. 
 This Note is subject to optional prepayment, in whole or from time to time in part, at the times and on the terms specified in the Note Purchase Agreement, but not otherwise. 

If an Event of Default occurs and is continuing, the principal of this Note may be declared or otherwise become due and payable in the
manner, at the price (including any applicable Make-Whole Amount) and with the effect provided in the Note Purchase Agreement. 

This Note shall be construed and enforced in accordance with, and the rights of the Issuers and the holder of this Note shall be governed
by, the law of the State of New York excluding choice-of-law principles of the law of such State that would permit the application of the laws of a jurisdiction other than such State. 

 

			
	Very truly yours,
	
	AMEDISYS, INC.
		
	By:	 	 
	Name:	 	
	Title:	 	
	
	AMEDISYS HOLDING, L.L.C.
		
	By:	 	 
	Name:	 	
	Title:	 	

  
 Exhibit B-2

 EXHIBIT C 
 EXHIBIT 2 
 [FORM OF
SERIES B NOTE] 
 AMEDISYS, INC. 

AMEDISYS HOLDING, L.L.C. 
 6.28% SERIES B SENIOR NOTE DUE MARCH 25, 2014 

 

			
	No. RB-[    ]	  	[Date]
	$[            ]	  	PPN: 02343@ AB6

 FOR VALUE RECEIVED, the undersigned, AMEDISYS, INC., a corporation organized and existing under
the laws of the State of Delaware and AMEDISYS HOLDING, L.L.C., a limited liability company organized and existing under the laws of the State of Louisiana (collectively, the “Issuers”) hereby promise to pay to
[                        ], or registered assigns, the principal sum of
[                                    ] Dollars (or so much thereof as
shall not have been prepaid) on March 25, 2014, with interest (computed on the basis of a 360-day year of twelve 30-day months) (a) on the unpaid balance hereof at the rate of 6.28% per annum, from the date hereof, payable
semiannually, on the 25th day of March and September in each year, commencing with the March 25th or September 25th next succeeding the date hereof, until the principal hereof shall have become due and payable, and (b) to the extent
permitted by law, on any overdue payment of interest and, during the continuance of an Event of Default, on such unpaid balance and on any overdue payment of any Make-Whole Amount, at a rate per annum from time to time equal to the greater of
(i) 2% per annum above the rate otherwise in effect with respect to this Note or (ii) 2% over the rate of interest publicly announced by JPMorgan Chase Bank, N.A. from time to time in New York, New York as its “base” or
“prime” rate, payable semiannually as aforesaid (or, at the option of the registered holder hereof, on demand). 

Payments of principal of, interest on and any Make-Whole Amount with respect to this Note are to be made in lawful money of the United
States of America at the principal office of JPMorgan Chase Bank, N.A. in New York, New York or at such other place as the Issuers shall have designated by written notice to the holder of this Note as provided in the Note Purchase Agreement referred
to below. 
 This Note is one of a series of 6.28% Series B Senior Notes (herein called the “Notes”),
aggregating $30,000,000 in original aggregate principal amount, issued pursuant to the Note Purchase Agreement, dated as of March 25, 2008 (as from time to time amended, the “Note Purchase Agreement”), among the Issuers and the
respective Purchasers named therein and is entitled to the benefits thereof. Each holder of this Note will be deemed, by its acceptance hereof, to have (i) agreed to the confidentiality provisions set forth in Section 20 of the Note
Purchase Agreement and (ii) made the representation set forth in Section 6.2 of the Note Purchase Agreement. Unless otherwise indicated, capitalized terms used in this Note shall have the respective meanings ascribed to such terms in the
Note Purchase Agreement. 

  
 Exhibit C-1

 This Note is a registered Note and, as provided in the Note Purchase Agreement, upon
surrender of this Note for registration of transfer accompanied by a written instrument of transfer duly executed, by the registered holder hereof or such holder’s attorney duly authorized in writing, a new Note for a like principal amount will
be issued to, and registered in the name of, the transferee. Prior to due presentment for registration of transfer, the Issuers may treat the person in whose name this Note is registered as the owner hereof for the purpose of receiving payment of
principal, interest and any Make-Whole Amount and for all other purposes, and the Issuers will not be affected by any notice to the contrary. 
 This Note is subject to optional prepayment, in whole or from time to time in part, at the times and on the terms specified in the Note Purchase Agreement, but not otherwise. 

If an Event of Default occurs and is continuing, the principal of this Note may be declared or otherwise become due and payable in the
manner, at the price (including any applicable Make-Whole Amount) and with the effect provided in the Note Purchase Agreement. 

This Note shall be construed and enforced in accordance with, and the rights of the Issuers and the holder of this Note shall be governed
by, the law of the State of New York excluding choice-of-law principles of the law of such State that would permit the application of the laws of a jurisdiction other than such State. 

 

			
	AMEDISYS, INC.
		
	By:	 	 
	Name:	 	
	Title:	 	
	
	AMEDISYS HOLDING, L.L.C.
		
	By:	 	 
	Name:	 	
	Title:	 	

  
 Exhibit C-2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00209-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00209-of-00352.parquet"}]]